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ABSTRACT 
The purpose of this work was to examine the effectiveness of several replacements 
for antibiotics in broiler chickens using bacterial challenge models. For this work, 
pathogen challenge models were developed using three model pathogens; two human 
pathogens (Salmonella enteritidis and Campylobacter jejuni), and one poultry pathogen 
(Clostridium perfringens). The first set of experiments involved the selection and use of 
2 model probiotics; Bifidobacterium animalis and Lactobacillus fermentum. Oral 
administration of either probiotic did not significantly reduce (P < 0.05) the level of 
intestinal colonization by either S. enteritidis or C. jejuni in experimentally infected 
broiler chickens. The next set of experiments examined the effectiveness of orally 
administered,  pathogen-specific antibodies obtained from hyperimmunizing laying 
hens in controlling bacterial infections with S. enteritidis, C. jejuni or Clostridium 
perfringens in broiler chickens. Regardless of the concentration, or mode of 
administration, anti-S. enteritidis hen-egg antibodies or anti-C. jejuni hen-egg 
antibodies were unable to significantly reduce (P < 0.05) the intestinal colonization by 
either pathogen in experimentally infected broiler chickens. Likewise, administration of 
anti-C. perfringens hen-egg antibodies did not reduce intestinal colonization by C. 
perfringens, and actually exacerbated the clinical outcome of this important poultry 
pathogen by significantly increasing (P < 0.05) intestinal lesions scores compared to 
negative control birds. Lastly, the effect of dietary protein source on intestinal C. 
perfringens populations was investigated. In broiler chickens experimentally infected 
with C. perfringens and fed diets which varied in the source of dietary protein, it was 
shown that birds fed fish meal, meat/bone meal, feather meal and potato protein 
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concentrate had significantly higher intestinal C. perfringens counts than the birds fed 
corn gluten meal, soy or pea protein concentrates or the control diet (P < 0.05). Further, 
it was shown that the glycine content of the diets and ileal contents was significantly, 
positively correlated with C. perfringens numbers in ileum and cecum. It is concluded 
that although the intervention strategies employed in these studies show promise, diet 
composition clearly had the largest effect on intestinal bacterial populations. Further 
studies are required to examine both the impact that diet and these intervention 
strategies have on the factors which control intestinal colonization by pathogens on a 
case by case basis.  
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1. INTRODUCTION 
Although it was Pasteur who postulated that microorganisms are necessary for 
normal life, it has only been in the past several decades that the microflora of the 
gastrointestinal tract has generated much interest amongst researchers. With the 
exception of pathogens and the diseases that they cause, there was little appreciation of 
the normal intestinal microflora. In recent years however, there has been an increase in 
our understanding of the gastrointestinal tract, the microflora contained therein, and 
how management practices can influence both. Recent research is revealing that the 
gastrointestinal tract is a much more complex ecosystem than was previously thought, 
and one in which the host and the microflora are dependant upon each other for health 
and survival.  
Historically, the intestine has been viewed as a black box with inputs and outputs 
the only parameters that were considered. The introduction of in-feed antibiotics in the 
1950s effectively controlled disease and improved animal performance (Dibner and 
Richards, 2005; Jones and Ricke, 2003), however the effectiveness of antibiotics also 
reduced the importance of understanding gastrointestinal microbiology. As a result, 
there is a huge gap in our understanding of the gastrointestinal microflora and its effects 
on the host at the most basic level. Current research however, has demonstrated the 
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important role that the normal gastrointestinal microflora plays in animal health and 
nutrition, as well as highlighting the ecological significance of intestinal pathogens.  
According to the Chicken Farmers of Canada (2004), chicken consumption is 
increasing both nationally and provincially in Saskatchewan. In terms of consumption, 
chicken is second only to beef and in 2003 an average of 30.5kgs of chicken per person 
was consumed. In this same year, Saskatchewan had 97 chicken producers which 
generated 30,456,000 kgs of meat, with farm receipts totaling $50.5 million dollars. 
Clearly, the production of chicken in Saskatchewan represents a significant contribution 
to the economy which is expected to not only continue, but increase as well. Since 2000 
there has been a 24.7 % increase in production and it is projected to increase between 
2.0 and 2.5% annually in the future. Thus, the future profitability of the poultry industry 
in Saskatchewan and elsewhere depends upon not merely maintaining current 
production levels, but increasing them with to meet increasing demand. In addition to 
maintaining production however, profitability also requires that poultry products are 
safe and free from the microorganisms that cause food-borne illnesses. Consumer 
awareness, coupled with high profile food-borne disease outbreaks, have eroded 
consumer confidence in the meat and poultry supply and consequently the presence of 
bacterial pathogens in the food supply is a major concern to both the consumer and 
regulatory agencies. Thus, an improved understanding of the microbial ecology of the 
gastrointestinal tract, including methods to manage it, is important to the sustainability 
of the poultry industry in Saskatchewan and around the world in the prevention of 
disease and foodborne illness and the enhancement of the growth performance of broiler 
chickens.  
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2. LITERATURE REVIEW 
2.1. The gastrointestinal microflora 
The gastrointestinal tract of monogastric animals harbors a large collection of 
different microbial species. The number of species in humans is generally estimated to 
be between 400 and 500, although some researchers have suggested that this may 
represent only 10% of the total number of species present (Berg, 1996; Finegold et al., 
1975; Savage, 1977). Recent research has suggested that the chicken gastrointestinal 
microflora may contain more that 650 species of which more than half are from 
previously unknown bacterial genera (Apajalahti et al., 2004). The number, type, and 
distribution of microorganisms that comprise the normal flora differ between animal 
species, however, in general there is a population gradient from the proximal to distal 
ends of the gut (Engberg et al., 2000), where overall anaerobic and facultatively 
anaerobic gram positive microorganisms appear to dominate (Mackie et al., 1999; 
Savage, 1977). Even the stomach, which was once thought to be free of indigenous 
microflora, is home to microorganisms albeit in low numbers compared to the colon 
(Lee et al., 1993). Like the stomach, the proximal two-thirds of the small intestine was 
once thought to be free of a resident microflora. The cultured microbes were thought to 
be transient, presumably associated with food as it passed through the intestine. It has 
been shown, however, that the mucosal epithelium of the duodenum and jejunum can 
harbor microflora under certain circumstances, and may in fact be permanently 
 4
colonized by bacteria (Ciampolini et al., 1996; Savage, 1986). However, it is the distal 
one-third of the small intestine and the large intestine which constitute the bulk of the 
intestinal microflora. The total microbial count of the gastrointestinal tract is estimated 
to be over 1014 microorganisms and thus outnumbers the total 1013 cells in the adult 
human body (Savage, 1977). 
2.2. Acquisition and succession 
The microflora begins to colonize the gastrointestinal tract of young animals 
immediately at birth or hatch, and the interaction between host and microflora continues 
throughout life. In well recognized and characterized patterns of succession, the 
microflora develops in response to exposure, as well as host health and nutrition (Amit-
Romach et al., 2004; Lu et al., 2003; Mackie et al., 1999; Simpson et al., 1999; van der 
Wielen et al., 2002b). These patterns of succession have been found to be similar in 
chicks, piglets, calves, and humans (Mackie et al., 1999). Sterile at hatch or birth, the 
complete microflora or climax community develops slowly and depending on the 
animal species, may take up to 2 years to fully develop as is the case with humans (Falk 
et al., 1998). Bacteria of the gastrointestinal tract for the most part derive their energy 
from dietary components consumed by the host. These dietary components are either 
resistant to the host’s digestive enzymes or slowly digested, and as a result the 
composition and structure of the diet is largely responsible for the microbial community 
of this ecosystem (Apajalahti et al., 2004). The impact of diet may be readily be 
observed in community structure and diversity (Apajalahti et al., 2001; Gibson et al., 
1996; Reid and Hillman, 1999). 
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Recent research by Apajalahti et al. (2004) has shown that within 24h post-hatch 
ileal and cecal bacterial numbers in chickens can be as high as 108 to 1010 per gram of 
digesta, respectively. During the subsequent 3 days these numbers have been observed 
to increase to between 109-1011 and remain relatively stable for the following 30 days. 
The authors also suggested that although the numbers remain relatively stable, the 
composition of the microflora undergoes major changes over the same time period. The 
total number of gut bacteria observed in chickens is consistent with the bacterial 
numbers found during the same time period in other animal species (Snel et al., 2002). 
Using molecular methods to evaluate the composition of the gastrointestinal microflora, 
Lu et al. (2003) demonstrated that community stability based on community profiles 
obtained from 16s gene sequences could be directly related to the age of the bird. 
During the first week of life it has been shown that enterococci and lactobacilli 
dominate in the crop, duodenum and ileum while it has been shown that in the cecum it 
is coliforms, enterococci and lactocbacilli that are the predominant microorganisms 
(Barnes, 1972; Mead and Adams, 1975; van der Wielen et al., 2000). Initially at low 
numbers, after only 5 to 6 hours there may be 109-1010 CFU/g of feces in chicks (Snel et 
al., 2002). 
Many of the initial microorganisms found in the gastrointestinal tract are transient 
and are not able to actually colonize the gastrointinal tract (Barnes et al., 1980). 
However, both colonizing and transient microorganisms change the physicochemical 
properties of the intestinal environment which results in a suitable environment for the 
succession of subsequent microbial species which ultimately comprise the climax 
community of mature animals. The observed changes occur via the production of 
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various fermentation products such as volatile fatty acids (VFAs) (van der Wielen et al., 
2000), which inhibit some species of gastrointestinal microorganisms, and a more 
reduced intestinal environment which is necessary for the obligate anaerobes which 
dominate the intestinal microflora of mature animals particularly in the cecae (Lan et 
al., 2002; Apajalahti et al., 2004).  
2.3. Climax community 
Over time, a stage in community succession is achieved whereby the community 
has become relatively stable through successful adjustment to its environment. This 
stability is termed a “climax community”. The climax community is similar in various 
animal species, however considerable variation does occur (Zhu et al., 2002), and 
although the climax community is composed of predominantly anaerobic gram positive 
species (Barnes et al., 1972; Lu et al., 2003), research has shown that the presence of 
facultative anaerobes or aerobes is needed for optimum intestinal health and disease 
resistance (Goren et al., 1984). The factors which contribute to the development and 
maintenance of the normal climax community of adult chickens include environment, 
host-specific determinants, and the intestinal compartment in which they are found (Lu 
et al., 2003; van der Wielen et al., 2002b). 
The gastrointestinal microflora of older birds, and thus the climax community, has 
been shown to be more diverse than in younger birds using either traditional (Barnes et 
al., 1972; van der Wielen et al., 2000) or molecular methods (van der Wielen et al., 
2002b) for the identification of gastrointestinal microflora. This is particularly evident 
in the cecum where there appears to be a much more complex microbial community, 
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compared to the small intestine and crop where only a few species appear to dominate 
(Lu et al., 2003; van der Wielen et al., 2002b). 
The climax community found in healthy animals serves to protect the animal from 
the colonization by pathogenic species (Mackie et al., 1999; Savage, 1977). 
Interestingly, despite the recognition that a completely developed microbial community 
is required for optimal health, and that the time required to reach adulthood by chickens 
is approximately 30 weeks, broiler chickens are marketed well before this age. It is 
important, therefore, to bear in mind that the microflora of a bird this age, although 
relatively stable, has not yet fully developed (Lu et al., 2003). 
2.4. Inter-species differences in intestinal microflora 
Compared to many other animal species, the chicken has a relatively simple 
modified gastric system. Perhaps the most significant difference between modern 
poultry and mammalian agricultural species is the absence of a weaning period and 
complete separation of hen and chick before hatch. This separation leads to an artificial 
pattern of succession in terms of the colonizing species, and ultimately delays the 
development of the climax community (Snel et al., 2002). In addition to rearing 
practices, however, the physiological and anatomical differences between chickens and 
other monogastric animals result in additional differences in their gastrointestinal 
microflora (Hooper and Gordon, 2001; Lu et al., 2003). As well as species-specific 
differences, research using molecular methods for the enumeration and identification of 
gastrointestinal microflora has shown that differences between individuals can also be 
observed (van der Weilen et al., 2002). This suggests that there exist host-specific 
factors which are important for the establishment of the gastrointestinal microflora, and 
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these factors potentially lead to the development of a unique gastrointestinal microbial 
community in chickens (Lu et al., 2003; Tannock et al., 1982). 
2.5. Spatial distribution of chicken gastrointestinal microflora 
Virtually all the studies where traditional bacterial culture methods have been used 
consistently report that there are 1011 to 1012 bacteria per gram of intestinal contents in 
the lumen of an adult broiler chicken (Fuller, 1992). Within the small intestine the 
observed intestinal microflora appears to be established and stable after 2 to 3 weeks 
post-hatch (Lu et al., 2003; Snel et al., 2002), whereas in the more microbially complex 
cecum stability is not achieved until much later at 6 to 7 weeks (Coloe et al., 1984), and 
may even take as long as 30 weeks (Lu et al., 2003). As with all animal species, there 
are spatial differences within the gastrointestinal microflora of chickens. With the 
exception of the right and left cecae, each compartment of the gastrointestinal tract has 
been shown to have its’ own specific microbial community (van der Weilen et al., 
2002). These differences are both in the number of microorganisms found, but also in 
the type. Some of these major differences are outlined below. 
2.5.1. Crop 
The crop serves as a storage organ which partially regulates the entry of the ingested 
food into the gizzard. This allows the chicken to eat its daily ration in a short period and 
digest it later. Considerable microbial growth occurs in the crop which might contribute 
to feed digestion and is therefore beneficial to the bird (Champ et al., 1983). The time 
feed is in the crop depends on a number of factors including the amount, consistency, 
moisture content, and access to feed. These factors also influence the microbial growth 
found in this organ. Some of the bacterial species isolated from the crop of chickens 
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include Escherichia coli, enterococci, staphylococci, lactobacilli, Campylobacter spp., 
and Salmonella spp. (Frei et al., 2001), however many of these are transient species and 
after the first week the dominant species found in the crop is Lactobacilli (Barnes et al., 
1972; Mead, 1997; Mead and Adams, 1975; van der Wielen et al., 2002b; van der 
Wielen et al., 2000). On the epithelial surface of the crop the Lactobaccillus spp. form a 
layer of cells up to 3 deep which restricts the available crop epithelium surface for 
colonization by pathogenic species (Fuller, 1973). Shortly after feeding, the pH of the 
crop decreases to approximately 5.0 due to the bacterial production of lactic acid. This 
reduced pH may contribute to digestion via the hydrolysis of stored feed, but also may 
have a bacteriostatic or bacteriocidal activity against bacteria sensitive to this pH, and 
consequently may protect the chicken from ingested pathogenic bacteria (Fuller, 1977; 
Mead, 1997). Thus, the crop also has an influence the microbial ecology of the entire 
gastrointestinal tract (Maisonnier et al., 2003). 
2.5.2. Proventriculus (stomach ) and ventriculus (gizzard) 
The proventriculus is a glandular organ which corresponds to the stomach of 
mammals. It produces a gastric juice containing hydrochloric acid and proteolytic 
enzymes. However, it differs from the mammalian stomach in that little mixing or 
holding of food occurs in it. From the proventriculus, the food moves to the ventriculus 
(or gizzard), a muscular organ where the food is ground and mixed with the gastric 
juice. It has been shown that similar to the crop, the low pH of the gizzard does define 
the microbial population in distal portions of the gastrointestinal tract (Bjerrum et al., 
2005). In terms of the microbial population that it harbors, a search of the literature 
shows little is known. The harsh environmental conditions found in these two regions of 
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the gastrointestinal tract would suggest that the vast majority of the culturable microbes 
found are transient, however the discovery of resident microbes in the stomach of 
humans (Lee et al., 1993) indicates that these regions of the chicken intestine may also 
have a resident population of microorganisms with an as of yet unknown role in the 
microbial ecology of the gastrointestinal tract.  
2.5.3. Small intestine 
In the small intestine, the majority of the ingested nutrients are broken down, 
digested, and adsorbed by the host. Thus in terms of microbial nutrition, this is an 
environment with intense competition for available nutrients. As in the crop, 
Lactobacillus spp. appear to dominate in the small intestine (Barnes et al., 1972; Mead, 
1997; Mead, 1997; van der Weilen et al., 2002).  Using molecular techniques, Lu et al. 
(2003) found that out of a total number of 614 16s rDNA sequences present, 
Lactobacillus spp. comprised 68.5% of the total number. The remainder of the ileal 
community was composed of smaller numbers of other species, including members 
from 14 other genera. These researchers also demonstrated population shifts within the 
ileal community over time. This age-dependant development has been observed by 
others (van der Wielen et al., 2002b), and has been shown to be unique to this region of 
the gastrointestinal tract.  
2.5.4. Cecum 
The cecae of adult chickens provides a relatively stable environment and as such 
harbors the largest and most complex microbial community within the gastrointestinal 
tract (Mead, 1997). As well as being the largest assemblage of gastrointestinal 
microbes, it is also the most varied (Apajalahti et al., 2001; Mead and Adams, 1975; 
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van der Weilen et al., 2002; Zhu et al., 2002). As with all regions of the gastrointestinal 
tract, there are age-dependant differences in the microbial community within the cecum 
(Amit-Romach et al., 2004; Lu et al., 2003). At 1 day of age the number of bacteria 
found in cecal contents is as high as 106 CFU/mL (van der Wielen et al., 2000).  The 
population is composed of predominantly Lactobacillus spp. and is not significantly 
different from the small intestine (Lu et al., 2003). As the chicken ages, however, the 
Lactobacillus spp. become less dominant as both the number and diversity of the cecal 
microflora increase (Barnes et al., 1972; Lu et al., 2003; Mead and Adams, 1975; van 
der Wielen et al., 2002b). The increase can take up to 30 days or longer to develop 
(Coloe et al., 1984; Lu et al., 2003). These changes make the microbial ecology of the 
cecae much different compared to other parts of the gastrointestinal tract (Lu et al., 
2003), but as with other regions of the gastrointestinal tract, they are in response to the 
available nutrients and environmental conditions. Lu et al. (2003) were able to 
determine that regardless of age, species from the genera Clostridium, Eubacterium, and 
Ruminococcus dominated the microbial community of the cecum.  
2.6.  Importance of gastrointestinal microflora in health and disease 
Work with germ-free animals has shown that the gastrointestinal microflora has an 
enormous amount of influence on the development of the chicken gastrointestinal tract 
(Furuse and Okumura, 1994). The observed effects include an influence on the gross 
physiology of the intestine, but also immunological, nutritional and protective 
influences as well. The host microflora also provides a number of nutritional 
compounds, which have a profound effect on the overall health and performance of the 
host animal. Clearly, the effects are beneficial; however, the benefits are offset to a 
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certain degree by a physiological cost to the host animal. The commensal microflora 
competes with the host for ingested nutrients, secretes toxic compounds, and stimulates 
a continuous immune response. Thus, the challenge for gastrointestinal microbiologists 
and animal scientists is to understand the microbial ecology and microbiological 
processes of the gastrointestinal tract in such as way as to maximize the benefits, while 
minimizing the cost of maintaining what is essentially another organ. 
2.6.1. Benefits 
Perhaps the most beneficial effect of the gastrointestinal microflora is the resistance 
to colonization by pathogenic microorganisms it provides. This phenomenon has been 
termed as bacterial resistance, colonization resistance, or competitive exclusion. 
Although the exact mechanisms by which this protection is conferred are unknown, it is 
hypothesized to be due to the production of antimicrobial compounds such as organic 
acids and bacteriocins, stimulation of the immune system, or competition for nutrients 
and specific epithelial binding sites (Nurmi et al., 1992; Rolfe, 1997). Experimental 
evidence to support this hypothesis can be demonstrated using germ-free chickens 
which are much more susceptible to colonization by pathogens than conventional 
animals (Fukata et al., 1991; Hudault et al., 1985). 
The gastrointestinal microflora also produce a number of nutrients that become 
available to the host animal, including volatile fatty acids (VFAs), amino acids, B 
vitamins and vitamin K (Savage, 1986; Snel et al., 2002; Wostmann, 1996). VFAs such 
as lactate, acetate, propionate, and butyrate produced from fermentable carbohydrates 
(Barnes, 1979; van der Wielen et al., 2000) are absorbed by the gut and serve as an 
energy source for the gut itself as well as the body as a whole (Hegde et al., 1982). In 
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addition to being a source of energy, the volatile fatty acids have been shown to 
stimulate the growth of intestinal epithelial cells, which leads to increased villus size 
and intestinal absorptive capacity (Cook and Bird, 1973; Tellez et al., 1993). 
Additionally, they also contribute to determining the microorganisms present in the 
distal portion of the gastrointestinal tract via bacterial inhibition and immunomodulation 
of the host (Hara et al., 2003; van der Wielen et al., 2000). The role that microbially 
derived amino acids and vitamins may contribute to chicken health using modern 
rearing practices is unclear (Dibner and Richards, 2005). 
As well as providing colonization resistance and the production of nutrients, the 
normal microflora also benefit the host by stimulating both specific and non-specific 
host defenses which serve to protect the host from not only invading pathogenic 
microorganisms, but also the inappropriate growth of normal gastrointestinal 
microorganisms. These host defenses include production of the mucus layer which 
overlies the gastrointestinal epithelium and acts as a barrier to the epithelium itself 
(Deplancke and Gaskins, 2001; Sharma and Schumacher, 1995), as well as both specific 
and non-specific immunity (Jeurissen et al., 2002). This constant stimulation of the 
immune system has physiological cost to the host. It has been estimated that in pigs, for 
example, the production and secretion of protective IgA amounts to several hundred 
grams of protein during the production cycle of a market pig (Gaskins, 2001).  
2.6.2. Costs  
In addition to the metabolic costs associated with immunostimulation and the above 
described production and secretion of immunoglobulin, even under ideal conditions 
there are additional metabolic costs associated with the gastrointestinal microflora. 
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Perhaps most importantly, is the direct competition for nutrients ingested by the host. It 
has been estimated that the microflora may consume 10 to 20% of the ingested 
carbohydrates and protein that would otherwise be available to the host (Apajalahti et 
al., 2004).  
The resident microflora also decrease fat digestibility through the catabolism of bile 
(Knarreborg et al., 2004), especially by Lactobacillus spp. (Baron and Hylemon, 1997). 
The deconjugation of bile by the gastrointestinal microflora thus impairs lipid 
absorption and may also produce a number of anti-nutritional catabolites from the 
degradation of bile (Baron and Hylemon, 1997). 
Additional toxic catabolites are produced by the gastrointestinal microflora through 
the fermentation of amino acids (Gaskins, 2001). These toxic catabolites contribute to 
increased epithelial cell turnover rates, as well as contribute to diarrhea in the host 
animal (Gaskins, 2001). Not only does the gastrointestinal microflora increase epithelial 
cell turnover rates due to the production of toxic catabolites, they also shorten the 
lifespan of absorptive enterocytes and mucus secreting goblet cells (Gaskins, 2001).  
2.7. The role of normal microflora in disease prevention 
Despite the metabolic costs, however, there appears be an advantage to the presence 
of the gastrointestinal microflora, and for the most part a symbiotic relationship has 
developed over time (Farthing, 2004). The indigenous or commensal microorganisms 
benefit from the protection and various niches that the gastrointestinal tract provides, 
and the host benefits from the presence of the microflora. Perhaps the most important 
benefit of the normal microflora is in the prevention of disease. The presence of a fully 
developed and healthy gut microflora serves to reduce the chance of intestinal 
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colonization by non-indigenous microflora especially pathogens (Snel et al., 2002; van 
der Waaij et al., 1971). This has been termed colonization resistance and is the basis for 
many probiotic strategies. The inability of pathogenic microorganisms to attach and 
colonize the epithelial surface also reduces their translocation across this important 
barrier and their ability to cause disease in the animal host (Wells, 1990). Research 
using germ-free animals has shown that in the absence of intestinal microflora, animals 
are much more susceptible to pathogen colonization than conventional animals (Harp et 
al., 1992; Srivastava, 1978; Wells et al., 1988; Wells et al., 1982), however the exact 
mechanisms by which the normal intestinal microflora impede colonization by 
pathogens is unclear. Proposed mechanisms include colonization resistance (Corrier et 
al., 1991; Gorbach et al., 1988), secretion of antimicrobial compounds such as volatile 
fatty acids (van der Wielen et al., 2002a) or bacteriocins (Gusils et al., 1999; Portrait et 
al., 1999), and direct stimulation of immune system (Jeurissen et al., 2002). 
2.8. Normal microflora as the cause of disease 
The normal microflora contains many microorganisms that can be pathogenic to the 
host under certain conditions. These opportunistic pathogens are always present, but 
only cause disease when the finely balanced intestinal ecosystem is perturbed. Under 
these conditions the microorganism can proliferate in the gastrointestinal tract and 
subsequently translocate across the epithelial barrier resulting in disease or death of the 
host (Farthing, 2004). This can occur when there is intestinal overgrowth of a 
commensal microorganism in the gastrointestinal ecosystem (Fukata et al., 1991), 
defective barrier function (Farthing, 2004), or a compromised immune status of the host 
(Shanahan, 2002). Oftentimes these conditions result from a primary infection due to a 
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pathogenic bacteria or virus (Bano et al., 2003; Glisson, 1998; Pakpinyo et al., 2003). In 
addition to opportunistic pathogens, many commensal microorganisms have the 
potential to become pathogenic. Transfer of genetic material encoding one or more of a 
series of virulence factors has been shown to transform a commensal microorganism to 
a pathogenic microorganism (Ewers et al., 2004). Thus, the relationship that the host 
has with the intestinal microflora, although beneficial, is not without a certain degree of 
risk. 
2.9. Bacterial pathogens and their effect on poultry production 
Even in the absence of disease, both opportunistic and overtly pathogenic 
microorganisms can be isolated from the gastrointestinal tract of chickens. The presence 
of these microorganisms is ultimately the cause of gastrointestinal infections in poultry 
which reduce intestinal health and contribute to reduced flock performance. In addition 
to the pathogens which cause disease in poultry, poultry may act as a reservoir of 
human pathogens (Mead et al., 1999). Control strategies for the reduction in enteric 
diseases are almost exclusively delivered via the feed, however the overall low 
incidence of enteric diseases in modern production systems is also a function of 
improvements in general poultry husbandry, nutrition, feed quality and veterinary 
surveillance programs (Dekich, 1998). In terms of the loss to producers annually, it is 
difficult to estimate, however any strategies which reduce the incidence of disease in 
poultry are clearly important to all facets of the industry. To date, preventative medicine 
has been the most successful strategy used to date, including the use of preventative 
feed medication or antibiotic growth promoters (Dekich, 1998).  
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2.9.1. Poultry pathogens 
A number of enteric bacterial disease are recognized in poultry, some of which are 
primarily limited to the gastrointestinal tract, whereas others move beyond the confines 
of the gastrointestinal tract and affect a number of organs (Porter, 1998). Common 
enteric diseases affecting chickens and the bacterial pathogens that cause them include; 
necrotic enteritis caused by Clostridium perfringens Type A or C (Al-Sheikhly and 
Truscott, 1977),  colibacillosis caused by E. coli as either a primary or secondary 
pathogen (Dho-Moulin and Fairbrother, 1999), fowl cholera caused by Pasteurella 
multocida (Rhoades and Rimler, 1989), salmonellosis caused by number of Salmonella 
spp. including pullorum and gallinarum (Porter, 1998), and spirochetosis caused by at 
least 2 species of Brachyspira, formerly known as Serpulina (Stephens and Hampson, 
2001).  
2.9.2. Human foodborne pathogens associated with poultry 
United States statistics gathered for the year 1999 indicate that foodborne illnesses 
from bacterial pathogens were responsible for over 76 million cases of reported 
illnesses, and the loss of work, income, and healthcare visits cost the US economy 
approximately 7 to 10 billion dollars (Mead et al., 1999). Some of the pathogenic 
bacteria most commonly reported in cases of foodborne illness include Campylobacter 
jejuni, Salmonella spp., Escherichia coli O157:H7, Staphylococcus aureus, Clostridium 
spp., and Listeria monocytogenes. Of these pathogens, Campylobacter jejuni and 
Salmonella are the number 1 and 2 most common causative agent of foodborne illnesses 
commonly associated with poultry meat and poultry consumption in Canada (Public 
Health Agency of Canada, 2005). In addition, it is important to note that neither of these 
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bacteria is commonly pathogenic to poultry, and thus chickens merely serve as a 
reservoir for these important human pathogens. This fact, combined with the foodborne 
illness statistics, illustrates the need for a comprehensive understanding of the factors 
which contribute to their persistence, and elimination in the gastrointestinal ecosystem. 
2.9.3. Intensive production of poultry 
The newly hatched chick’s normal colonization resistance is conferred via the 
establishment of normal gut microflora. However, the normal gut microflora is obtained 
through the ingestion of healthy adult bird fecal matter, and thus is precluded when hen 
and chicks are reared separately. Once individual chicks are infected, these pathogenic 
microorganisms spread rapidly to infect the entire flock. Canadian nation-wide surveys 
revealed that 76.9% of randomly selected chicken broiler flocks were Salmonella spp. 
positive, S. enteritidis being one of the main species (Poppe et al., 1991), and that 
between 77 and 100% of poultry flocks are C. jejuni positive (Munroe et al., 1983). 
During processing these bacteria may cross-contaminate both chicken meat, and 
processed chicken products, that are then packaged and sent for retail distribution. A 
study in the United States revealed that 83% of retail chickens were also C. jejuni  
positive (Kinde et al., 1983). 
Through the introduction of rigid hygienic measures, it is possible to breed and rear 
poultry free of these pathogens, however, the cost to the industry would be prohibitive 
and economically disastrous. Instead, antibiotic therapy is used extensively for the 
control of poultry bacterial diseases. This can, however, lead to the development of 
antibiotic resistance which has become a concern for both human and animal health 
care practitioners. Furthermore, the Gram-positive normal flora present in the gut is 
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itself inhibitory to Salmonella and Campylobacter spp. and is reduced by the use of 
growth-promoting antibiotics. The reduction in this flora provides pathogens with a 
competitive edge and may result in overt disease. 
2.10. Use of antibiotics in agriculture 
Antibiotics have been widely used in the livestock and poultry industries since their 
discovery more than 50 years ago (Dibner and Richards, 2005), and soon afterwards the 
beneficial effect of their inclusion in poultry rations was reported by Moore et al. 
(1946) and Stokstad and Jukes (1951). In the years following their discovery and first 
application, antibiotics used as growth promoters (AGP), have made them an extremely 
important tool in the efficient production of certain animal species. At therapeutic levels 
antibiotics help to prevent disease in animals and to treat diseases (Bywater, 2004), 
however at sub-therapeutic levels in diets, antibiotics improve growth rate and 
efficiency of feed utilization, reduce mortality and morbidity, and improve reproductive 
performance (Feed Additive Compendium, 2000).   
Although the exact means by which antibiotics improve performance and feed 
efficiency are not clear, they are thought to reduce the total number and/or total number 
of species of bacteria in the gastrointestinal tract (Collier et al., 2003; Gaskins et al., 
2002). This hypothesis is supported by the lack of response to antibiotics when they are 
administered to germ-free animals (Coates et al., 1963), and the reduced benefits from 
antibiotics when management practices aimed at reducing bacterial exposure are 
employed. In reducing the microbial load within the intestinal environment, the 
competition for nutrients and production of toxic metabolites outlined in section 3.5.2 
are reduced.  
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2.10.1. Control of pathogens using medicated feed 
As well as improving animal performance, the use of AGP also improves animal 
health by reducing both clinical and sub-clinical disease caused by poultry pathogens. 
This indirect benefit of AGP has been demonstrated by the increase in therapeutic 
antibiotic treatment of enteric diseases in poultry due to the removal of AGP from 
poultry diets in the EU (Bywater, 2005). In terms of food safety AGP also reduce 
human pathogens in the gastrointestinal tract of poultry. While the specific reduction in 
pathogens is not the primary reason for the inclusion of AGPs in poultry diets, they do 
reduce the intestinal numbers of pathogens as a function of the non-specific reduction in 
gastrointestinal microbes. This includes the control of pathogenic bacteria such as 
Escherichia coli O157:H7 and Clostridium perfringens, (Stanley et al., 1996; Verstegen 
and Williams, 2002). Depending on the antibiotic used however, there have been some 
reports of increased pathogen shedding when AGPs were administered in feed (Barrow, 
1989). 
2.10.2. Types of antibiotics and their mode of action 
The most common types of antimicrobials used in feed are listed in Table 2.1. 
Mechanistically, these antibiotics work by inhibiting or interfering with a number of 
different biochemical pathways including protein synthesis, cell wall synthesis, DNA 
and RNA synthesis, or folic acid synthesis (Davies and Webb, 2004). The end result is 
an overall reduction in the number of susceptible microorganisms. The observed effects 
outlined in Table 2.2 are hypothesized to be the result of 1) inhibition of sub-clinical 
infections from pathogenic microorganisms, 2) reduction in growth depressing 
microbial metabolites, 3) reduced competition for nutrients by gastrointestinal 
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Table 2.1. Antimicrobials commonly used in poultry in Canada (After Boulianne, 
1999). 
preventive
preventive
preventive
preventive
monensin sodium
lasalocid sodium
salinomycin sodium
naduramycin ammonium
Ionophores
curative
curative
curative
tetracycline
chlortetracycline
oxytetracycline
Tetracyclines
curative
curative
trimethroprim-sulfa
sulfaquinoxaline
Sulfamides
preventivevirginiamycinStreptogramin
curativeenrofloxacinQuinolones
curative
curative
erythromycin
lincomycin
Macrolides
preventiveceftiofurCephalosporines
curative
curative
amoxicillin
penicillin
Betalactamines
preventivezinc bacitracinBacitracin
preventive
curative
curative
curative
gentamicin
neomycin
streptomycin
spectinomycin
Aminoglycosides
UseName of the antibioticFamily
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Table 2.2. Summary of reported physiological, nutritional and metabolic effects of 
growth promoting antimicrobials (After Gaskins et al., 2002). 
Gut microbial urease
Fecal fat excretionMucosal cell turnover 
Fatty acid oxidationFecal moisture 
Bile degradation productsGut wall weight
Aromatic phenolsGut wall length 
Toxic amine productionVitamin synthesisGut wall diameter 
Ammonia productionGut energy lossFood transit time 
Decrease
Plasma nutrients
Calcium absorption
Glucose absorption
Fatty acid absorption
Trace element absorption
Vitamin absorption
Gut alkaline phosphataseNitrogen retentionFeed intake 
Liver protein synthesisEnergy retentionNutrient absorption
Increase
MetabolicNutritionalPhysiological
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microorganisms, 4) enhanced uptake and utilization of nutrients via the thinner 
intestinal wall associated with antibiotic-fed animals (Francois, 1962; Gaskins et al., 
2002; Visek, 1978).  
In 1995 93% of all starter diets, 97% of grower diets, and 86% of all finisher diets 
fed to broiler chickens in the United States contained an AGP and although levels of 
AGP in broiler rations have declined in the United States since the mid 1990s, presently 
they are included in approximately 60% of all broiler diets (Chapman and Johnson, 
2002). In the United States this decrease may reflect consumer concerns over the 
perceived health risks to humans, however in European countries legislation has 
resulted in their discontinued use.  
2.11. Future of antibiotics as feed additives 
Despite the recognized benefits that AGP provide to both producers and consumers, 
as far back as 1951 there has been concern over their use because of the issue of 
antimicrobial resistance (Elam et al., 1951). The use of antimicrobial drugs in food 
animals, including food producing animals, parallels their use in humans, and many of 
the concerns about the increase antimicrobial resistance stem from the belief that 
continual exposure to antibiotics in feed ultimately selects for antimicrobial resistance. 
This is particularly of concern with antibiotics that are used as animal feed additives and 
in human medicine (Levy, 2000; Tollefson and Miller, 2000). The observed increase in 
antimicrobial resistance in food animals is seen as a potential source of antimicrobial 
resistance genes which may ultimately spread to human pathogenic bacteria, and has 
sparked much debate and an increase in research examining alternatives to AGP 
(Bywater, 2004). 
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2.12. Alternatives methods to control pathogenic microorganisms 
The debate over the risks associated with the use of AGP in feed has fueled interest 
in alternative means to control disease and maintain current production levels. Although 
research using alternatives to AGP is in its’ infancy, some positive results have been 
obtained. Some of these methods are outlined below. 
2.12.1. Probiotics and competitive exclusion cultures 
One of the most well characterized means to reduce enteric disease is through the 
administration of live bacteria, or probiotics. Probiotics have been defined as “a live 
microbial feed supplement which beneficially affects the host animal by improving its 
intestinal balance” (Fuller, 1989), and their beneficial effects have been recognized for 
over a century (Patterson and Burkholder, 2003). In the early 1970s, studies aimed at 
reducing the ability of Salmonella to colonize the intestinal tract of chickens, 
demonstrated that very effective protection of newly hatched chicks could be achieved 
with the administration of adult chicken microflora (Nurmi et al., 1992; Nurmi and 
Rantala, 1973; Rantala and Nurmi, 1973). These cultures are known as competitive 
exclusion cultures, and like probiotics, inhibit the colonization of the chicken intestine 
by pathogenic bacteria blocking the ability of pathogens to attach to the intestine by 
occupying binding sites normally occupied by the pathogens (Nurmi et al., 1992). More 
recently it has been shown that probiotics not only inhibit or block the ability of 
pathogens to attach to epithelial surfaces, but also limit pathogen colonization through 
competition for nutrients and production of antibacterial substances such as VFAs and 
bacteriocins (Corrier et al., 1991; Edens et al., 1997). These are thought to inhibit 
pathogens by producing environmental conditions which may be suboptimal for their 
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growth. Recent work has demonstrated that in addition to the above mechanisms, 
pathogen inhibition may be the result of a more subtle and complex phenomena such as 
communication between epithelial cells and gastrointestinal microorganisms (Hooper 
and Gordon, 2001), and modulation of components of the immune system (Jeurissen et 
al., 2002). 
The administration of probiotic organisms to control pathogens in poultry is 
common practice in some parts of the world (Verstegen and Williams, 2002), especially 
in Japan and Europe (Patterson and Burkholder, 2003). Much of the research using 
probiotics has focused on Lactobacillus and Bifidobacterium spp. This focus is due, in 
part, to the fact that they are normal inhabitants of the chicken intestine and are thought 
to play an important role in resistance to infection. These microorganisms have also 
been shown to be sensitive to stress and respond to it with decreased intestinal numbers 
(Patterson and Burkholder, 2003). As well as these prokaryotic organisms, it has been 
shown that eukaryotic organisms, including Saccharomyces boulardii and 
Saccharomyces cerevisiae, also have the ability to bind Salmonella spp., thus interfering 
with the attachment of the pathogen to the intestinal wall (Spring et al., 2000). The in 
vivo administration of Saccharomyces cerevisiae has also been shown to positively 
affect performance when administered to broilers (Onifade et al., 1999). In addition to 
the benefits that Saccharomyces cerevisiae administration may have on broiler chickens 
during the grow out period, the administration of Saccharomyces boulardii has been 
shown to reduce pathogen load during transport to slaughter (Line et al., 1997). It has 
also been shown that there is a positive effect on the number of probiotic bacteria such 
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as Bifidobacterium and Lactobacillus spp. when Saccharomyces spp. are administered 
(Belem and Lee, 1998). 
While the administration of one or a few species of probiotic bacteria has been 
shown to be beneficial, administration of very complex, undefined assemblages of 
indigenous gut microflora has been shown to be the most effective strategy for probiotic 
administration. However, the large-scale production of these complex mixtures in a 
consistent manner has proven to be a difficult challenge. In addition to production 
difficulties, government approval for complex, undefined, probiotic mixtures has been 
unable to be secured. This is due, in part, because the underlying protective mechanisms 
by which probiotics and competitive exclusion cultures work is not fully understood and 
requires further research. This includes a clear understanding of the microorganisms 
themselves as well as the gastrointestinal conditions in which they proliferate. 
2.12.2. Prebiotics  
Prebiotics have also generated a significant amount of interest as a replacement for 
AGP (Patterson and Burkholder, 2003) and for their ability to improve animal health 
(Verstegen and Williams, 2002). They have been described as “non digestible food 
ingredients that beneficially affect the host by selectively stimulating the growth and/or 
activity of one or a limited number of bacteria in the colon leading to an improvement in 
host health” (Gibson and Roberfroid, 1995). In the context of poultry nutrition, these 
prebiotics also include soluble and insoluble non-starch polysaccharides (NSP).  These 
NSP represent the main substrates for bacterial fermentation in the hindgut (Choct et 
al., 1999), and as such they may alter the gastrointestinal microflora by inhibiting the 
growth of pathogenic species and/or encouraging the growth of beneficial species 
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(Chung and Day, 2004; Hidaka et al., 1990; Mitsuoka et al., 1987; Tokunaga et al., 
1986). Much of the research using prebiotics to alter intestinal microflora has been done 
in humans and has centered around the use of fructose, mannose, and galactose (Hidaka 
et al., 1990). In poultry, however, most of the research has been done using 
mannanoligosaccarides (Daskiran et al., 2004; Sims et al., 2004), fructooligosaccarides 
(Bailey et al., 1991; Oyarzabal and Conner, 1995; Waldroup et al., 1993; Xu et al., 
2003), and isomaltooligosaccarides (Chung and Day, 2004).  
Feeding fructooligosaccaharides Bailey et al. (1991) demonstrated a reduction in the 
ability of Salmonella typhimurium to proliferate in the gastrointestinal tract of chickens. 
The observed reduction was enhanced when the authors co-administered a competitive 
exclusion culture, which is consistent with the research of others (Hinton et al., 1990). 
The authors demonstrated in vitro that S. typhimurium did not utilize the 
fructooligosaccharide as a sole source of carbon, and thus the observed results were due 
to the fructooligosaccharide being used as substrate by beneficial bacteria which were 
increased with the addition of the competitive exclusion culture. In addition to 
fructooligosaccharide, mannanoligosaccharides have been used to reduce cecal 
colonization by Salmonella enterica (Fernandez et al., 2002), however rather than 
serving as substrate for beneficial intestinal microflora, it has been shown that 
mannanoligosaccharides are capable of agglutinating certain pathogens in vitro . Thus, 
as well as serving as substrate for growth, some oligosaccharides may also 
preferentially bind to bacterial surface lectins which may inhibit the ability of pathogens 
to attach to epithelial cells. 
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Although the administration of dietary fibre to chickens has been shown to produce 
beneficial results, research is needed to support the value of prebiotics in the development 
of a functional product. For example, a more thorough understanding of the mechanisms 
by which they act to support a healthy gut environment, alone and in combination with 
other methods used in the control of salmonella and campylobacter in the poultry 
industry, is needed if they are to see widespread use (Patterson and Burkholder, 2003). 
2.12.3. Passive transfer of immunity 
2.12.3.1. Hen egg antibodies 
A highly attractive and effective alternative approach for the control of potential 
pathogens present in the intestinal tract is the administration of specific neutralizing 
antibodies in the diet. The advantage of feeding antibodies with the diet is that they 
provide a continuous control of potential pathogens and do not result in the development 
of antibiotic resistant strains of microorganisms. Previous work done in other animal 
models suggests that hen egg antibodies (HEA) can be effective in the control of some 
pathogens (Imberechts et al., 1997; Marquardt et al., 1999; Wiedemann et al., 1991; 
Yokoyama et al., 1997; Yokoyama et al., 1992). Compared to other antibody sources, 
vaccination of laying hens provides a cost effective source of antibodies, with egg yolks 
containing as much as 25 mg of immunoglobulin per mL of yolk (Rose et al., 1974). A 
laying hen can produce approximately 300 eggs per year and the volume of one egg yolk 
is approximately 15 mL, which could supply close to 100 g of antibody per hen per year; 
an amount which has the potential to neutralize a large bacterial population. The egg yolk 
containing the antibodies can be spray-dried without loss of activity and can be fed 
directly to the chicken. Administration of HEA in this manner has been shown to be 
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effective for the treatment of a number enteric pathogens including enterotoxigenic E. coli 
in pigs (Imberechts et al., 1997; Marquardt et al., 1999) and calves (Ikemori et al., 1992), 
Salmonella spp. in calves (Yokoyama et al., 1998a), mice (Peralta et al., 1994; Yokoyama 
et al., 1998b), and humans (Sugita-Konishi et al., 2000), and Helicobacter pylori in 
humans (Shin et al., 2002). In addition to enteric bacterial infections, HEAs have shown 
promise in the treatment of viral infections as well (Bartz et al., 1980; Ebina et al., 1990; 
Hiraga et al., 1990; Kuroki et al., 1993). Although positive results have been obtained for 
some pathogens in other animal species, very little research however, has been done to 
assess the ability of hen-egg antibodies to reduce or eliminate enteric pathogens in 
poultry.  
2.12.3.2. Plantibodies 
The widespread use of antigen-specific antibodies for prophylaxis and therapy may 
require the administration of large quantities of antibody, and although present sources 
of antibody such as hen-egg antibodies may provide a suitable product of relatively high 
quantity and quality, alternate means for there production have been investigated 
(Hayden et al., 1997). Recombinant antibody technology may provide the antibody 
products required by producing them in transgenic plants (Berghman et al., 2005; 
Franconi et al., 1999; Stoger et al., 2002), or bacteria (Franconi et al., 1999). By far the 
most economical source of specific antibodies is derived from plants. The the cost of 
producing 1 gram of purified antibody antibodies in maize estimated to be 
approximately $0.10 USD (Berghman et al., 2005). Antibodies originally expressed in 
tobacco plants (Hiatt and Ma, 1992), are now produced in seed crops which in terms of 
animal feeds is the most practical and economical (Berghman et al., 2005). Importantly, 
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pathogen-specific recombinant proteins have been expressed as functional secretory 
IgA (Ma et al., 1995). Realistically, however, consumers are wary of transgenic plants 
and overcoming this may ultimately be one of the biggest obstacles to research, 
production, and use in animal feeds. 
2.12.4. Bacteriophage  
Bacteriophage are viruses that infect and kill bacteria. This bactericidal activity 
makes them candidates for the control of gastrointestinal bacteria, especially pathogens 
of both animal and human concern (Huff et al., 2005). Ironically, when bacteriophage 
were first discovered in the early 1900s their potential as a therapeutic agent was 
recognized, but the discovery and use of antibiotics resulted in the discontinuation of 
research on bacteriophage as therapeutics (Barrow and Soothill, 1997). Recent concerns 
over the use of AGP in feed has now increased interest in using them again to treat 
intestinal diseases and to reduce the incidence of foodborne illness from infected meat 
products (Alisky et al., 1998; Huff et al., 2005). They have been shown to be effective 
in reducing E. coli induced diarrhea in calves, piglets, and lambs (Smith and Huggins, 
1983, 1982; Smith et al., 1987). Using a murine model, they have also been shown to be 
effective in treating infections due to E. coli (Smith and Huggins, 1982), as well as 
Enterococcus faecium (Biswas et al., 2002), Acinetobacter baumanii and Pseudomonas 
aeruginosa (Soothill, 1992), and Staphylococcus aureus (Matsuzaki et al., 2003). In 
chickens they have been shown to protect from a lethal injection of E. coli (Barrow et 
al., 1998). 
In addition to treatment of bacterial infections, bacteriophage have been shown to be 
effective in reducing the pathogen load on poultry meat (Goode et al., 2003). Goode et 
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al. (2003) demonstrated that lytic bacteriophage were capable of reducing the number 
of culturable Salmonella enteritidis and Campylobacter jejuni on chicken skin when 
applied to experimentally infected carcasses. 
The use of bacteriophage to treat disease may be possible, however, there are some 
limitations which include their specificity, ability to act as a vehicle for pathogenic 
genetic material, issues concerning regulatory acceptance, protection of property rights, 
and practical routes of administration (Huff et al., 2005). Despite these limitations, 
bacteriophage have the potential to help fight bacterial enteric infections and reduce the 
incidence of foodborne illness.  
2.12.5. Natural antimicrobials 
Many natural products have observed antimicrobial activity and have thus been used 
to preserve foods for centuries, and their ability to inhibit the growth of intestinal 
pathogens has been examined. These include berries and their phenolics which have 
been shown to be inhibitory to some intestinal pathogens (Puupponen-Pimia et al., 
2005; Rauha et al., 2000), tannic acid (Kubena et al., 2001), essential oils from various 
plants including aniseed, rosemary, and celery (Elgayyar et al., 2001; Mitsch et al., 
2004; Verstegen and Williams, 2002). Although in principle these compounds have 
been shown to be inhibitory towards intestinal pathogens, research has yet to be done 
which demonstrates their commercial suitability.  
2.12.6. Organic acids 
Organic acids or volatile fatty acids (VFA) were originally added to animal feed to 
inhibit fungal growth (Paster, 1979), however competitive exclusion studies in poultry 
implicated these same compounds in the cecae of chickens with reduced Salmonella 
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counts (Barnes et al., 1979; Corrier et al., 1994; Corrier et al., 1995). Subsequent in 
vitro research examined the ability of VFAs to inhibit the intestinal microflora of 
poultry and confirmed that they do have antibacterial activity. Although the exact 
mechanisms by which VFAs inhibit intestinal microflora are unclear (Ricke, 2003), 
undissociated VFAs are thought to penetrate the cell membrane of bacteria and 
dissociate in the more alkaline cytoplasm, hereby increasing the inward leak of protons 
so that efflux of protons is not rapid enough to alkalinize the cytoplasm (Cherrington et 
al., 1991; Kashket, 1985). Species that have been shown to be sensitive to various 
organic acids include pathogens of both human and animal concern such as Salmonella 
and E. coli (Hinton and Linton, 1988; Izat et al., 1990), as well as Campylobacter 
(Chaveerach et al., 2004). In vivo studies examining the effect of VFAs on the 
gastrointestinal microflora intestinal pathogens have most often used formic acid 
(Hinton and Linton, 1988; McHan and Shotts, 1992) and propionic acid (Hinton and 
Linton, 1988; Hume et al., 1993; McHan and Shotts, 1992), however other VFAs have 
included acetic acid and hydrochloric acid (Chaveerach et al., 2002). In addition to 
reduced growth in the presence of VFAs, van Immerseel et al. (2003) showed that the 
ability of Salmonella enteritidis to invade chicken epithelial cells in vitro is influenced 
by the VFAs. 
The promising results obtained from research has resulted in the development of a 
number of commercial products, however more research is required to improve their 
effectiveness. Of particular interest is the phenomenon of acid tolerance, including the 
stress response and virulence factors which allow for resistance in more acidic 
environments (Ricke, 2003). 
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2.12.7. Diet 
Using percent G+C to characterize diet-dependant differences in the gastrointestinal  
microflora, Apajalahti et al. (2001) examined a number of Finnish poultry farms. They 
found that when the gastrointestinal profiles from different farms were compared, diet 
turned out to be the strongest determinant in of the cecal bacterial community structure. 
To assess the affect that diet has on the microbial ecology of the gastrointestinal tract, a 
number of different dietary factors have been examined for their ability to influence the 
gastrointestinal microflora. 
Processing of feed has been shown to affect the microbial ecology and pathogen 
load of the intestine (Apajalahti et al., 2001; Engberg et al., 2002). Engberg et al. 
(2002) examined the  influence of pelleting versus mash feeds and demonstrated that 
simple factors such as particle size can alter the intestinal populations of several 
microbial species, most notably the number of Clostridium spp., with pellet-fed birds 
having a lower number of intestinal Clostridium spp.. In addition to feed processing, the 
influence of dietary constituents have on the intestinal microflora have also been 
examined. 
Dietary protein has been shown to influence the intestinal numbers of a number of 
pathogenic bacteria including C. perfringens (Drew et al., 2004) and C. jejuni 
(Udayamputhoor et al., 2003). This may be a function of the amino acid profile of 
various proteins which may upregulate specific virulence factors in pathogenic bacteria 
such as S. enteritidis (Durant et al., 2000) or are immunomodulatory and influence the 
ability of a pathogen to cause disease (Takahashi et al., 1997), however high protein 
 34
diets must certainly also alter the  intestinal microflora by preferentially increasing 
proteolytic members.  
 In addition to the inclusion of carbohydrate prebiotics outlined above, the type of 
dietary grain has been shown to influence the intestinal microflora, including pathogens 
(Annett et al., 2002; Guo et al., 2004; Guo et al., 2003; Phillips et al., 2004; Riddell and 
Kong, 1992). As with dietary protein, this may be due to the positive selective pressure 
that the type and level of dietary carbohydrates found in grain may exert on the 
saccharolytic members of the chicken intestinal microflora. However, there also appears 
to be an immunomodulatory effect from certain polysaccharides even at low inclusion 
rates (Benson et al., 1993; Chen et al., 2003; Gulsen et al., 2002; Kleessen et al., 2003; 
Takahashi et al., 2000).  
The dietary fat added to poultry diets has been shown to not only have an effect on 
bird performance (Golian and Maurice, 1992), but also intestinal populations in broiler 
chickens (Danicke et al., 1999). Considerable research has shown that there is a link 
between dietary lipids and the immune status of chickens (Konjufca et al., 2004; 
Mandal et al., 2004; Puthpongsiriporn and Scheideler, 2005; Sijben et al., 2003), 
however as a consequence of fat digestion, fatty acids and monoglycerides are liberated 
which have been shown to have antibacterial effects in rats (Sprong et al., 1999). 
Sprong et al. (1999) observed that rats fed diets high in bovine milk had reduced levels 
of L. monocytogenes in experimentally challenged animals, but not S. enteritidis. In 
poultry, the effect of dietary fat has been shown to reduce intestinal colonization by 
pathogens such as C. perfringens (Knarreborg et al., 2002). Despite these positive 
findings however, little research has been done which examines the relationship 
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between type, lipid profile, and the level of fat inclusion and the microbial ecology of 
the chicken gastrointestinal tract. 
As well as the above dietary components, the addition of exogenous enzymes to 
broiler diets has been shown to affect the gastrointestinal microbial populations. Dietary 
enzymes shown to influence the microbial ecology of the chicken intestine include β-
glucanase (Choct et al., 1999) and xylanase (Hubener et al., 2002). Although the effect 
of exogenous enzymes on pathogenic bacteria has not been extensively examined, the 
addition of xylanase has been shown to reduce intestinal colonization by clostridia, 
salmonella, and C. jejuni (Apajalahti and Bedford, 1998; Fernandez et al., 2000). 
Clearly, the observation that dietary components and processing can significantly 
alter the gastrointestinal environment and microflora underscores the potential that these 
factors may have in controlling gastrointestinal pathogens for improved bird health and 
performance, and thus should be examined further. 
2.13. Conclusions 
Intensification of poultry production systems combined with consumer fears over 
antibiotic residues and resistance have raised the need to find alternatives to AGP in 
feed. To date, the use of probiotics and various feed ingredients or additives which 
favor the growth of beneficial microorganisms at the expense of human and animal 
pathogens have proven less than satisfactory under all conditions, and there is a gap in 
our current understanding of the factors which contribute to the functioning of 
gastrointestional ecosystem. In addition to the need for more sophisticated methods for 
the detection and enumeration of the community members within the gastrointestinal 
mileu, there is an equal deficiency in our current understanding of the roles that the 
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various community members have both within the community and in the 
gastrointestinal ecosystem as a whole. In terms of intervention strategies, it is beginning 
to become clear is that there does not appear to be a single treatment that will be able to 
replace AGPs. Ultimately any effective management strategy may require the use of a 
number of treatments which are either being presently researched or currently in use, 
but with mixed results. 
Based on these observations, the overall objective of these studies was to investigate 
the effect of probiotics, hen egg antibodies and dietary proteins on intestinal 
colonization by three model pathogens; Salmonella enteritidis, Campylobacter jejuni 
and Clostridium perfringens. 
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3. THE EFFECT OF ADMINISTRATION OF LACTOBACILLUS 
FERMENTUM AND BIFIDOBACTERIUM ANIMALIS FOR THE CONTROL 
OF SALMONELLA ENTERITIDIS AND CAMPYLOBACTER JEJUNI IN 
BROILER CHICKENS 
 
3.1. Abstract 
Salmonella enteritidis and Campylobacter jejuni are the most prevalent human 
pathogens associated with poultry meat consumption. In this study, 10 Lactobacillus 
and 6 Bifidobacterium isolates were screened for their survivability in increasing 
concentrations of bile and decreasing pH. Based on these results, two model probiotics 
(Lactobacillus fermentum and Bifidobacterium animalis) were assessed in in vivo trials 
for their ability to inhibit the intestinal colonization of day-of-hatch broiler chicks by 
Salmonella enteritidis and Campylobacter jejuni. Compared to the negative control 
groups, administration of either L. fermentum or B. animalis via oral gavage for 7 
consecutive days did not significantly reduce (P < 0.05) the ileal or cecal colonization 
by either pathogen in experimentally challenged chicks. Although not statistically 
significant, administration of L. fermentum did result in fewer S. enteritidis positive 
livers and spleens in experimentally challenged chicks. These results suggest that 
although the intestinal survival of probiotic bacteria is essential for their use in feed 
supplements, it should not be used as the sole criterion for probiotic strain selection. In 
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addition, despite the fact that L. fermentum did not reduce ileal or cecal colonization by 
S. enteritidis using our infection model, there is some evidence that L. fermentum might 
reduce translocation of pathogens to spleen and liver. 
3.2. Introduction 
Modern poultry production practices leave chicks susceptible to colonization by a 
wide variety of both human and avian pathogens. The newly hatched chick’s normal 
colonization resistance is conferred via the establishment of normal gut microflora, 
however, the normal gut microflora is obtained by ingestion of healthy adult bird fecal 
matter. The separation of hen and chicks, as is the practice in the modern poultry 
industry, results in a delay in the development of the normal healthy adult microflora, 
during which time pathogenic microorganisms may become established in susceptible 
birds (Bailey et al., 1994). Once birds are infected, the pathogens may be horizontally 
transferred within the flock and barns, which makes their complete eradication a 
difficult task. Furthermore, human pathogens such as Salmonella enteritidis (Bailey et 
al., 1994) and Campylobacter jejuni (Craven et al., 2001) may become established in 
the intestinal tract of chickens. Typically these bacteria do not cause disease in poultry 
and thus their presence may go undetected in birds (Garriga et al., 1998). For example, 
Canadian nation-wide surveys have revealed that 76.9% of randomly selected chicken 
broiler flocks were Salmonella spp. positive, S. enteritidis being one of the main species 
(Poppe et al., 1991), and that between 77 and 100% of poultry carry C. jejuni (Munroe 
et al., 1983). Cross-contamination during processing may result in these pathogens 
being spread from intestinal contents to chicken meat, which is then packaged and sent 
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for retail distribution. A study in the United States revealed that 83% of retail chickens 
were C. Jejuni positive (Kinde et al., 1983). 
According to the Public Health Agency of Canada, (2003), Campylobacter jejuni 
and Salmonella spp. are the number 1 and 2 most common foodborne pathogens 
associated with poultry consumption in Canada. In the year 2000, the number of 
reported cases of Campylobacterosis and Salmonellosis in Canada was 12,352 and 
5655, respectively (Public Health Agency of Canada, 2003). These statistics represent a 
significant cost to the Canadian economy and illustrate the need for a more thorough 
understanding of the factors which contribute to the persistence of pathogenic 
microorganisms in poultry, as well as means for their elimination from the 
gastrointestinal tract.   
Probiotics have been defined as “a live microbial feed supplement which 
beneficially affects the host animal by improving its intestinal microbial balance” 
(Fuller, 1989), and their administration to control pathogens in poultry is common 
practice in some parts of the world (Verstegen and Williams, 2002), especially in Japan 
and Europe (Patterson and Burkholder, 2003). In North America, however, a lack of 
solid scientific research clearly demonstrating a beneficial effect, as well as an inability 
to obtain government approval, has somewhat limited their widespread use (Verstegen 
and Williams, 2002; Patterson and Burkholder, 2003). Much of the research using 
probiotics has focused on Lactobacillus and Bifidobacterium spp. due in part to the fact 
that they are normal inhabitants of the chicken intestine and are thought to play an 
important role in resistance to infection, but also because these populations appear to be 
sensitive to stress, responding to it with decreased intestinal numbers (Patterson and 
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Burkholder, 2003). Lactobacillus, Bifidobacterium and other lactic acid bacteria (LABs) 
are thought to aid in the prevention of disease, and exclusion of pathogenic 
microorganisms by competing for attachment sites on epithelial cells (competitive 
exclusion) (Fuller, 1977), production of antimicrobial compounds such as organic acids, 
hydrogen peroxide, and bacteriocins (Servin, 2004), and stimulation of the immune 
system (Perdigon et al., 2001). Although convincing results have been obtained in vitro, 
similar results in vivo have been more difficult to demonstrate. Thus, the objective of 
these studies was to evaluate the ability of Lactobacillus fermentum and 
Bifidobacterium animalis to reduce the intestinal colonization by Campylobacter jejuni 
and Salmonella enteritidis in day-of-hatch broiler chickens. 
3.3. Methods and Materials 
3.3.1. Pathogen selection and culture conditions 
A Salmonella enteritidis isolate of chicken origin was obtained from Dr. Manuel 
Chirino, Dept. of Veterinary Microbiology, Western College of Veterinary Medicine, 
University of Saskatchewan, Saskatoon, SK., Canada.  As a selective marker for use in 
challenge studies, the S. enteritidis isolate was screened for both Nalidixic Acid  and 
Novobiocin resistance (S. enteritidisNal,Novo). Briefly, the S. enteritidisNal,Novo  mutant 
was obtained by growing the original S. enteritidis isolate for 6 hours aerobically at 
37ºC in Trypticase Soy Broth (TSB) (Difco, VWR International, Mississauga ON, 
Canada). The cells were harvested by centrifugation (3640 x g for 15 min at 4ºC), 
washed twice in phosphate buffered saline (PBS, pH 7.2), and resuspended in a minimal 
amount of PBS. The cells were then plated on Trypticase Soy Agar (TSA) containing 
25µg/mL Nalidixic Acid (Sigma, Sigma-Aldrich, Oakville ON, Canada ). The Nalidixic 
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Acid resistant colonies capable of growth were subsequently transferred to TSA 
containing  25µg/mL Novobiocin (Sigma, Sigma-Aldrich, Oakville ON, Canada ). This 
resulted in 20 double antibiotic resistant isolates. The growth curves of the 20 double 
mutants were compared to the original isolate in an in vitro experiment. Briefly, the 
original S. enteritidis isolate and all 20 S. enteritidisNal,Novo  mutants were grown for 6 
hours at 37ºC in TSA and TSA containing 25µg/mL Nalidixic Acid and Nalidixic Acid, 
respectively. The titre of these cultures were adjusted to ~ 1.5 x 102/mL, with 1.0 mL 
used to inoculate 50 mLs of the appropriate media. Based on the growth curves, a single 
isolate was chosen and used for all subsequent in vivo trials. A Nalidixic Acid resistant 
(125µg/ml) C. jejuni (C. jejuniNal) isolate of human origin was obtained from Dr. 
Dianne Taylor, Dept. of Microbiology, University of Alberta, Edmonton, AB, Canada, 
and was used for all in vivo trials using Campylobacter jejuni. The S. enteritidisNal,Novo  
mutant was grown aerobically in Trypticase Soy Broth (Difco, VWR International, 
Mississauga ON, Canada) at 37ºC. Lactobacillus fermentum cultures were anaerobically 
grown in MRS broth (Difco, VWR International, Mississauga ON, Canada) at 37°C. 
Bifidobacterium animalis cultures were anaerobically grown in TPY broth (pH 6.5) at 
37°C. The TPY broth consisted of (per litre) 10.0g trypticase, 5.0g phytone, 5.0g 
glucose, 2.5g yeast extract, 0.5g cystein-HCl, 2.0g K2HPO4, 0.5g MgCl2, 0.25g ZnSo4, 
0.15g CaCl2, 0.03 FeCl3, 1.0mL Tween-80. For all bacteria except C. jejuni, cultures 
were grown until late log phase (6 hours for S. enteritidis, overnight for L. fermentum 
and B. animalis), harvested by centrifugation (3640 x g for 15 min at 4ºC), washed 
twice and resuspended in phosphate buffered saline (PBS, pH 7.2) to a final titre of 1 X 
108 CFU/mL. The C. jejuni (Nalr) isolate was grown on blood agar plates containing 
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125µg/ml Nalidixic acid, aseptically scraped from plates, washed twice and 
resuspended in PBS as above. 
3.3.2. Probiotic selection and culture conditions 
To select a candidate probiotic strain of Lactobacillus, 7 isolates were obtained from 
the cecum of an adult laying hen reared in a battery cage. Using API CHL Medium and 
API 50 CH strips (bioMérieux Canada, St. Laurent QC, Canada) as per the 
manufacturers instructions, the presumptive Lactobacillus spp. isolates were positively 
identified as L. fermentum (two isolates), L. acidophilus (two isolates), L. delbrückii 
(two isolates), and L. salivarius. In addition to the cecal isolates, 3 commercial cultures 
were used; a lyophilized commercial strain of L. acidophilus (Inst. Rosell-Lallemand, 
Montréal QC, Canada) and L. reuteri (BioGaia Biologics #11284) (BioGaia Biologics, 
Stolkholm, Sweden), as well as an ATCC strain (ATCC, Manassas VA, USA) of L. 
amylovorus (33198). The Bifidobacterium spp. candidates were chosen from ATCC 
stains; B. animalis (27536), B. suis (27533), B. thermophilum (25525), and B. 
pseudolongum (25526) or commercial strains;  B. longum (Chr. Hansen #701967) and 
B. bifidum (Inst. Rosell #75118). To select isolates most capable of withstanding the 
harsh conditions in the proximal intestine, all isolates were screened for acid and bile 
tolerance by exposure to increasing concentrations of porcine bile extract, and 
decreasing pH. Lactobacillus spp. and Bifidobacterium spp.. Bacterial cells were 
harvested as above, with 1.0 mL of each resuspended culture added to 9.0 mLs of either 
MRS or TPY broth for Lactobacillus spp. and Bifidobacterium spp., respectively. To 
assay the bile resistance of the isolates the MRS and TPY broth contained 0.0, 0.05, 
0.10, 0.20, 0.40, 0.60, 0.80, or 1.0% porcine bile extract (Sigma, Sigma-Aldrich, 
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Oakville ON, Canada). To assay the survivability of the isolates in low pH, the 
resuspended cells were also used to inoculate MRS and TPY broth which had the pH 
adjusted to 6.0, 5.5, 5.0, 4.5, 4.0, 3.5, 3.0, and 2.5 using HCl. The positive or negative 
growth was determined by comparing the number of cells in each tube at hour 0 
compared to growth after 24 hours growth, based on duplicate plating of cultures on the 
appropriate media. 
3.3.3. Birds and infection 
Experimental protocols were approved by the Animal Care Committee of the 
University of Saskatchewan and were performed in accordance with the 
recommendations of the Canadian Council on Animal Care (1993). Experimental birds 
were housed in heated battery cages at the Animal Care Facility of the Western College 
of Veterinary Medicine, University of Saskatchewan, Saskatoon, SK.  In all 
experiments day-of-hatch Ross 308 mixed-sex broiler chicks (Lilydale Hatchery, 
Wynyard SK) were used.  
3.3.4. Animal challenge experiments 
To assess the ability and colonization dynamics of the S. enteritidisNal,Nov and C. 
jejuniNal isolates in the gastrointestinal tract of day-of-hatch chicks, two separate 
experiments were conducted. In the first trial, 37 chicks were orally gavaged with 0.09 
mLs of an overnight culture of S. enteritidisNal,Nov, placed in the same cage and provided 
a commercial, non-medicated starter crumble (Co-op Feeds, Saskatoon, SK) and water 
ad libitum. At hours 0, 1, 2, 3, 6, 9, 12, 15, 18, 21, 24, two birds were euthanized by 
cervical dislocation and the contents from the jejunum, ileum and cecae enumerated as 
described below. In addition to the first 24 hours, at days 4, 7, and 14, an additional 5 
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birds were euthanized with the contents enumerated for S. enteritidis. For the first 24 
hours the intestinal contents were removed by rinsing the intestinal segments with 1.0 
mL of sterile PBS., whereas at days 4, 7, and 14 contents from each intestinal length 
was collected as described below. A second trial was conducted in which all 
experimental procedures were as described above except that the birds were orally 
gavaged with C. jejuniNal . 
To determine the ability of L. fermentum and B. animalis to reduce intestinal 
colonization by either S. enteritidis or C. jejuni, 4 separate trials were conducted in 
duplicate. In each trial 40 day-of-hatch broiler chicks were randomly assigned to either 
the experimental or control group. Both groups were orally gavaged with 0.9 mLs of a 
~1.0 X 108 CFU/mL resuspended culture of either S. enteritidis or C. jejuni as prepared 
above. The challenged chicks were provided a non-medicated starter crumble (Co-op 
Feeds, Saskatoon, SK) and water ad libitum. Three hours post-challenge, the chicks in 
the treatment group were administered the probiotic by orally gavaging 0.9 mLs of a 
~1.0 X 108 CFU/mL resuspended culture of either L. fermentum or B. animalis as 
prepared above. In each trial the chicks in the control group were orally gavaged with 
an equal volume of sterile PBS. The administration of the probiotic or PBS continued 
until day 7 of the experiment. On day 14 the birds were euthanized with ileal and cecal 
contents collected and plated as below. In trials where birds were challenged with S. 
enteritidis, the liver and spleen were aseptically removed and plated as below. 
3.3.5. Sample collection and pathogen enumeration 
In all experiments, the entire contents of the ileum and cecae were separately 
removed from each bird. The collected contents from each gut location was then mixed 
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thoroughly and a subsample of each was placed in sterile peptone containing 0.5% 
cysteine hydrochloride and immediately placed on ice. The subsamples were serially 
diluted and plated in duplicate using an automated spiral plater (Autoplate, Spiral 
Biotech Inc., Bethesda MD, USA). For the enumeration of C. jejuni, samples were 
plated on Modified Preston’s Campylobacter Isolation Agar (Oxoid) containing 
125µg/ml Nalidixic acid (Sigma) and incubated at 37°C for 48 hours in the appropriate 
atmospheric conditions (BBL271045 Campy-Pac; Becton Dickinson Microbiology 
Systems). Enumeration of S. enteritidis was done using Brilliant Green Agar (Difco) 
containing 25 µg/ml of Nalidixic acid and Novobiocin (Sigma), incubated for 16 hours 
aerobically. For experiments where birds were challenged with S. enteritidis, the spleen 
and liver for each bird was also aseptically collected, placed in sterile peptone 
containing 0.5% cysteine hydrochloride and immediately placed on ice. The spleen and 
liver was then diluted 1:10, homogenized (Brinkmann PT 10-35), and plated on 
Brilliant Green Agar (Difco) containing 25 µg/ml of Nalidixic acid and Novobiocin. 
3.3.6. Statistical analysis 
Individual birds were considered the experimental unit in all experiments. Bacterial 
numbers at each anatomical site were log transformed to normalize them prior to 
analysis. Statistical analyses of log10 transformed colony forming units were analyzed 
using the general linear model of SPSS (v.10.0.5, SPSS Inc, Chicago IL, USA). 
Treatment means were compared using the Ryan-Einot-Gabriel-Welsch multiple F test, 
and were considered significant when P < 0.05.  
3.4. Results 
Screening the S. enteritidis isolate for double antibiotic resistance resulted in 20 
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isolates capable of growing in 25µg/mL Novobiocin and Nalidixic acid. Although all 20 
isolates grew well compared to the original isolate, numbers 19 and 20 appeared to be 
equally fast growing compared to the original isolate (Table 3.1). Of these 2, #19 was 
chosen for all in vivo challenge studies. The ability of both pathogenic strains of 
bacteria to colonize and become established in the gastrointestinal tract of day old 
chicks was determined. The antibiotic resistant markers permitted us to monitor and 
follow population dynamics within the intestinal tract of challenged birds without any 
apparent loss in virulence. When birds were challenged with both S. enteritidis and C. 
jejuni, the pathogens were present in the entire gastrointestinal tract from 3 hours 
onward (Figures 3.1 and 3.2, respectively). In addition, intestinal colonization by S. 
enteritidis and C. jejuni was measured at days 4, 7, and 14 after the oral challenge 
(Figures 3.3 and 3.4, respectively). Thus the 3 hour time period required by both 
pathogens to become present in all compartments of the gastrointestinal tract of chicks 
determined the time at which all probiotics were initially administered in all in vivo 
trials.  
Based on their ability to grow in bile and low pH (Tables 3.2 and 3.3), L. fermentum 
and B. animalis were chosen as model probiotics. In addition to the ability of these two 
isolates to grow either as well as, or better, than the other strains. both were also of 
chicken origin. In replicated trials, both L. fermentum and B. animalis were unable to 
reduce or eliminate the level of either ileal or cecal colonization by C. jejuni (Tables 3.4 
and 3.5, respectively) or S. enteritidis (Tables 3.6 and 3.7, respectively). Administration 
of B. animalis or L. fermentum did not significantly reduce the translocation of S. 
enteritidis to the spleen or liver.  
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Table 3.1. Table showing the growth of double-antibiotic resistant S. enteritidis 
mutants compared to the non-antibiotic resistant original S. enteritidis strain. 
 
8.288.608.787.904.982.1620
8.048.748.847.954.952.20192
8.008.788.786.654.042.1718
7.958.018.846.953.402.1817
8.078.668.797.003.482.2216
8.358.788.797.004.312.1915
7.998.658.836.783.752.1714
7.918.788.797.004.362.2013
8.338.548.796.884.882.2112
8.008.708.785.003.002.1811
7.358.728.806.953.952.1410
8.347.898.815.483.752.169
8.658.328.817.304.302.198
8.568.818.825.303.232.227
7.998.548.787.004.002.266
7.958.328.807.014.012.205
7.958.828.846.904.472.144
7.338.878.827.003.282.183
7.897.998.797.284.472.172
7.788.328.787.153.412.201
8.208.648.657.814.702.161original
1286420Isolate
Time (hours)
1 Values are the log10 transformed CFU /mL average of two replicate cultures.
2 denotes isolate chosen for all in vivo and in vitro experiments .  
 
 48
  
0
2
4
6
8
10
0 1 2 3 6 9 12 15 18 21 24
Time (hours post-infection)
S.
 e
nt
er
iti
di
s 
C
ou
nt
s 
(lo
g 1
0 
C
FU
s/
g 
co
nt
en
ts
)
Jejunum
Ileum
Cecum
 
Figure 3.1. Graph showing the temporal distribution of the Nalr/Novor strain of 
Salmonella enteritidis in day-of-hatch Ross 308 broiler chicks. 
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Figure 3.2. Graph showing the temporal distribution of the Novor strain of 
Campylobacter jejuni in day-of-hatch Ross 308 broiler chicks. 
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Figure 3.3. Graph showing jejunal, ileal, and cecal colonization by the Nalr/Novor 
strain of Salmonella enteritidis broiler chickens. Bars represent the mean ± SEM of 
5 birds euthanized at days 4, 7 and 14. 
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Figure 3.4. Graph showing jejunal, ileal, and cecal colonization by the Novor strain 
of Campylobacter jejuni in broiler chickens. Bars represent the mean ± SEM of 5 
birds euthanized at days 4, 7 and 14. 
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Table 3.2. The effect of bile concentration and pH on the ability of Lactobacillus spp. to grow in MRS broth.  
 
 
- / -- / -- / -- / -+ / -+ / ++ / ++ / +L. amylovorus (ATCC #33198)
- / -- / -- / -- / -+ / -+ / ++ / ++ / +L. reuteri (BioGaia Biologics) )#11284)
- / -- / -- / -- / ++ / ++ / ++ / ++ / +L. acidophilus (Inst. Rosell)
- / -- / -- / -- / ++ / ++ / ++ / ++ / +L. salivarius
- / -- / -- / -- / -+ / ++ / ++ / ++ / +L. delbrückii (B)
- / -- / -- / -- / -- / -+ / ++ / ++ / +L. delbrückii (A)
- / -- / -- / +- / ++ / ++ / ++ / ++ / +L. acidophilus (B)
- / -- / -- / +- / +- / ++ / ++ / ++ / +L. acidophilus (A)
- / -- / -- / -- / -+ / -+ / ++ / ++ / +L. fermentum (B)
- / -- / +- / ++ / ++ / ++ / ++ / ++ / +1L. fermentum (A)2
1.0/2.50.8/3.00.6/3.50.4/4.00.2/4.50.1/5.0.05/5.50.0/6.0Lactobacillus Strain
Bile Concentration (%) / pH
1Cultures were incubated anaerobically overnight at 37ºC, with positive or negative growth represented by a + or – sign, respectively.
2Designates the strain chosen for all in vivo and in vitro experiments. 
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Table 3.3. The effect of bile concentration and pH on the ability of selected Bifidobacterium spp. to grow in TPY broth. 
  
- / -- / -- / -+ / -+ / ++ / ++ / ++ / +B. bifidum (75118)
- / -- / -+/ ++ / ++ / ++ / ++ / ++ / +B. longum (701967)
- / -- / -- / -+ / -+ / ++ / ++ / ++ / +B. pseudolongum (25526)
- / -- / -- / -- / -- / -- / -+ / ++ / +B. thermophilum (25525)
- / -- / -- / -- / -+ / ++ / ++ / ++ / +B. suis (27533)
- / -- / -+ / ++ / ++ / ++ / ++ / ++ / +1B. animalis (27536)2
1.0/2.50.8/3.00.6/3.50.4/4.00.2/4.50.1/5.0.05/5.50.0/6.0Bifidobacterium Strain (ATCC #)
Bile Concentration (%) / pH
1Cultures were incubated anaerobically overnight at 37ºC, with positive or negative growth represented by a + or – sign, respectively.
2Designates the strain chosen for all in vivo and in vitro experiments. 
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Table 3.4. Trial 1 and 2 mean Log10 CFU counts of Campylobacter jejuni in ileum 
and cecum of 14 day old broiler chickens with and without administration of 
Lactobacillus fermentum. 
 
 
0.470.44Pooled SEM
4.643.79L.  fermentum
4.793.92No probiotic
Trial 2
0.470.43Pooled SEM
5.003.62L.  fermentum
4.393.63No probiotic
Trial 1
CecumIleum
 
 
 
 
 
 
 
 
 
 
` 
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Table 3.5. Trial 1 and 2 mean Log10 CFU counts of Campylobacter jejuni in ileum 
and cecum of 14 day old broiler chickens with and without administration of 
Bifidobacterium animalis. 
 
 
0.460.47Pooled SEM
3.993.18B. animalis
3.713.28No probiotic
Trial 2
0.470.44Pooled SEM
3.842.72B. animalis
3.713.55No probiotic
Trial 1
CecumIleum
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Table 3.6. Mean Log10 CFU counts of Salmonella enteritidis in ileum, cecum, liver 
and spleen of 14 day old broiler chickens with and without administration of 
Lactobacillus fermentum. 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.230.200.430.41Pooled SEM
1.04 (7/19)0.90 (6/19)4.903.96L.  fermentum 
1.27 (10/20)0.93 (9/20)4.903.96No probiotic
Trial 2 
0.230.220.430.34Pooled SEM
1.46 (8/18)1.23 (6/18)5.014.07L.  fermentum 
1.76 (12/19)1.28 (9/19)14.863.89No probiotic
Trial 1 
SpleenLiverCecumIleum
1 Values in brackets represent the number of S. enteritidis positive birds/total number of birds sampled
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Table 3.7. Mean Log10 CFU counts of Salmonella enteritidis in ileum, cecum, liver 
and spleen of 14 day old broiler chickens with and without administration of 
Bifidobacterium animalis.  
 
 
0.230.200.440.41Pooled SEM
1.51 (7/19)1.00 (6/19)5.003.67B. animalis
1.27 (10/20)0.93 (9/20)4.443.82No probiotic
Trial 2
0.240.200.430.40Pooled SEM
1.44 (10/19)0.75 (8/19)4.893.47B. animalis
1.35 (9/19)0.90 (7/19)14.463.61No probiotic
Trial 1
SpleenLiverCecumIleum
1Values in brackets represent the number of S. enteritidis positive birds/total number of birds sampled  
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3.5. Discussion 
The ability to overcome the physico-chemical hurdles such as bile acid and low pH 
in the gastrointestinal tract dictates to a large extent the survival and subsequent 
proliferation of probiotic bacteria in the gastrointestinal tract (Fooks and Gibson, 
2002b). These selective pressures define which microorganisms will ultimately colonize 
the gut, and are most suited to competition with other microorganisms, especially 
pathogens (Garriga et al., 1998). In addition to being able to survive these hurdles, host 
specificity has been recognized and well documented (Barrow et al., 1980; Fuller, 1975; 
Suegara et al., 1975) Thus, in these studies isolation and selection of Lactobacillus and 
Bifidobacterium species was undertaken as the first step in assessing the suitability of 
these microorganisms as a probiotic for the reduction of intestinal colonization by either 
C. jejuni or S. enteritidis. 
Based on our results there were clear inter and intra-species differences in the ability of 
different strains of Lactobacillus and Bifidobacterium to grow in the presence of 
differing concentrations of bile, and at different pH. In some cases, however, strains 
grew equally well compared to B. animalis and B. bifidum. Thus, in choosing the 
Bifidobacterium sp. strains the origin of the isolates was also taken into consideration. 
Although we did not isolate any of the Bifidobacterium spp., the B. animalis was of 
chicken origin and was chosen for this reason. In this study we isolated 7 Lactobacillus 
spp. from the cecum of an adult hen, and compared their ability to grow in varying 
concentrations of bile and decreasing pHs with that of 3 commercial isolates. Compared 
to all other Lactobacillus species, L. fermentum A demonstrated the ability to grow 
under the lowest pH and in the presence of the highest concentration of bile. 
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Interestingly, this isolate was better suited to growth under these conditions than 
another L. fermentum isolated from the same chicken. Although we did not verify that 
these two isolates were capable of colonizing any regions of the intestinal tract, it has 
been shown that it is possible for Lactobacillus to colonize the intestinal tract of young 
chicks, even in the absence of any real affinity for intestinal epithelial cells (Rada et al., 
1995). In the absence of any direct evidence of intestinal colonization by either of our 
isolates, our administration of both probiotic strains attempted to ensure maximum 
intestinal presence by providing gavaging daily for 7 days. Although the gavaging titre 
was several orders of magnitude below the overall total number of microbes in the gut 
environment, it was similar to the total numbers of endogenous Lactobacillus and 
Bifidobacterium spp. found in the cecum, and thus ensured the number of probiotic 
probiotic organisms to exceed what would be normally present. 
Despite the demonstrated in vitro ability to survive both the pH and bile in the 
proximal intestine, neither L. fermentum nor B. animalis were capable of inhibiting the 
intestinal colonization by S. enteritidis and C. jejuni in either the ileum or cecum. Thus, 
survivability is not the only parameter that must be addressed when choosing probiotic 
strains. Other parameters that have been examined include the in vitro ability to inhibit 
the growth of other intestinal microorganisms and the ability of the probiotic strain to 
attach to the intestinal epithelial surface (Garriga et al., 1998; Mishra and Prasad, 2005), 
however survivability is often the only measurable parameter in vivo (Garriga et al., 
1998). In both experiments L. fermentum did not reduce intestinal colonization by S. 
enteritidis, however the actual number birds which were S. enteritidis positive in the 
liver and spleen were reduced (6/18 and 8/18 in trial 1 and 6/19 and 7/19 in trial 2 for 
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the liver and spleen, compared to the negative control groups which had a total of 9/19 
and 12/19 in trial 1 and 9/20 and 10/20 in trial 2, respectively). Together this would 
suggest that L. fermentum administration did appear to inhibit the intestinal 
translocation of S. enteritidis. The ability of both Lactobacillus and Bifidobacterium 
spp. to reduce translocation of Salmonella spp. has been previously reported both in 
vitro and in vivo (Gill et al., 2001; Hudault et al., 1997; Shu et al., 2000), however in 
our challenge model B. animalis was not able to inhibit the translocation of S. 
enteritidis. The inhibition of pathogen translocation may have been the result of at least 
two mechanisms; 1) bacterial interference whereby the probiotic organism restricts or 
blocks the ability of the pathogen to attach to epithelial cells (Patterson and Burkholder, 
2003) or 2) the immunostimulatory effect of Lactobacillus spp. (Erickson and Hubbard, 
2000; Perdigon et al., 2001). It has previously been shown that L. fermentum is able to 
attach to epithelial cells (Reid et al., 1993), which might limit the ability of S. enteritidis 
to attach to intestinal epithelial cells. Thus, although L. fermentum might not reduce the 
pathogen load, it might play an important role in protection against pathogens which 
have a contact-dependant, or Type-III secretion system (Wigley et al., 2002) such as 
Salmonella spp.. 
In addition to being able to simply colonize the intestinal tract, it has been 
hypothesized that Lactobacillus and Bifidobacterium spp. out-compete other intestinal 
microorganisms by producing antimicrobial compounds (Fooks and Gibson, 2002a, 
2002; Gibson and Fuller, 2000; Patterson and Burkholder, 2003; Servin, 2004). In this 
study, however, we did not assess the ability of either of the isolates to inhibit other 
microorganisms in vitro or in vivo. The production of antimicrobial fermentation end-
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products from fructooligosaccarides is a major mechanism by which Lactobacillus and 
Bifidobacterium spp. inhibit the growth of pathogenic microorganisms (Vandenbergh, 
1985), however our diets did not include the addition of any fructooligosaccharides. 
This might have contributed to the inability of either strain to inhibit intestinal 
colonization by S. enteritidis and C. jejuni, however this remains speculative. 
Additional factors which might have contributed to the inability of either L. 
fermentum or B. animalis to reduce intestinal colonization by S. enteritidis or C. jejuni 
include our infection model. To ensure a large, measurable, and consistent level of 
pathogen colonization, our infection model involved the infection of day-of-hatch 
chicks with a relatively high level of pathogen challenge (0.9 mLs of a ~1.0 X 108 
CFU/mL resuspended culture of either S. enteritidis or C. jejuni). Although the 
administration of pathogen on day-of-hatch is reasonable as this is when birds are the 
most vulnerable to pathogen colonization, the pathogen titre may have been too high for 
our probiotic treatment to have any effect regardless of the gavaging titre (0.9 mLs of a 
~1.0 X 108 CFU/mL), or duration (7 days). Other research has used challenge models 
which employed pathogen titres both similar to those used in this research (Orndorff et 
al., 2005), as well as titres considerably less (Al-Tarazi and Alshawabkeh, 2003), and 
many have shown positive results. Thus, it would be interesting to assess the effect that 
this same level of probiotic administration might have on different pathogen challenge 
titres. 
These studies suggest that when administered singly neither the L. fermentum nor B. 
animalis isolate used in these studies were capable of significantly reducing intestinal 
colonization by S. enteritidis or C. jejuni using our challenge model. There was an 
 62
indication, however, that L. fermentum may be able to reduce intestinal translocation of 
S. enteritidis. In terms of the spread and persistence of pathogens within poulry flocks, 
inhibition of pathogen translocation could be an important finding and thus further 
studies need to be undertaken which examine the conditions in which this might be 
possible. Selecting probiotic strains that are both host-specific and capable of 
withstanding the harsh intestinal conditions does not appear to ensure both survival and 
efficacy. Further research must be undertaken which might add additional insight into 
the factors which contribute to their successful application. 
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4. THE EFFECT OF HEN-EGG ANTIBODY ADMINISTRATION ON 
CAMPYLOBACTER JEJUNI AND SALMONELLA ENTERITIS 
COLONIZATION IN THE GASTROINTESTINAL TRACT OF BROILER 
CHICKENS 
 
4.1. Abstract 
Hen-egg antibodies have been shown to be efficacious in reducing pathogen 
shedding and gastrointestinal disease, however, their application for the reduction of 
pathogens such as S. enteritidis and C. jejuni in broiler chickens has not been 
investigated. In this study we examined the effectiveness of using hen-egg antibodies 
for the reduction of intestinal colonization by these important pathogens. Laying hens 
were vaccinated with either S. enteritidis or C. jejuni and the resulting eggs collected. 
Egg yolks were pooled, mixed in feed at 0.05% (w/w) or prepared for oral gavage by 
either water extraction using phosphate-buffered saline, or concentration using 
ammonium sulphate. The in vitro ability of the pathogen-specific antibodies to inhibit 
pathogen attachment to rat epithelial cells and porcine mucin was demonstrated. In 
addition, we demonstrated in vivo intestinal activity of anti-S. enteritidis antibody using 
day-of-hatch chicks. In separate trials, day-of-hatch broiler chicks were experimentally 
infected with either S. enteritidis or C. jejuni, and following challenge, hen-egg 
antibodies were administered in the feed or via oral gavage with either phosphate 
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buffered saline extracted (1/10 diluted) or ammonium-sulphate precipitated (10X 
concentrated) antibody. On days days 4, 7, and 11 jejunum, ileum, and cecum contents 
were collected and plate counts obtained for the appropriate pathogen. Despite 
measurable hen-egg antibody activity in vivo and in vitro, we were unable to 
demonstrate any significant reduction in the intestinal colonization by either S. 
enteritidis or C. jejuni. 
4.2. Introduction 
Salmonella enteritidis and Campylobacter jejuni are the two human pathogens most 
often associated with poultry meat. A Canadian nation-wide survey revealed that 76.9% 
of randomly selected chicken broiler flocks were contaminated with Salmonella spp. 
(Poppe et al., 1991), S. enteritidis being one of the main species. Another study reported 
that between 77 and 100% of poultry are carriers of C. jejuni (Munroe et al., 1983). 
During processing these bacteria are often disseminated from live poultry to chicken 
carcasses and by-products, which are then packaged and sent for retail distribution. A 
study in the United States revealed that 83% of retail chickens were contaminated with 
C. jejuni (Kinde et al., 1983). Proper handling and hygienic practices at the processing 
plant level reduces the risk of carcass contamination by these pathogens, however these 
practices alone have not eliminated them from the food supply. Clearly, an approach 
that includes their reduction at the farm level, before arrival at the processing plant, 
could lead to less contamination of meat by intestinal bacteria, and thus increase the 
safety of poultry meat and poultry meat products. 
Modern rearing practices, and their resulting high housing density, facilitates the 
vertical and horizontal transmission of pathogens within flocks making both S. 
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enteritidis and C. jejuni difficult to manage at the farm level. The epidemiology and 
transmission routes of both these human pathogens is only partially understood which 
makes intervention strategies difficult to design and implement (Guard-Petter, 2001; 
Sahin et al., 2002). Complicating matters is that both of these bacteria are not usually 
pathogenic to chickens and there is no apparent pathology or effect on growth and 
therefore no obvious need for any therapeutic strategies (Boyd et al., 2005; Guard-
Petter, 2001; Smith et al., 2005). Transmission of both S. enteritidis and C. jejuni can 
occur horizontally through the contaminated feces of infected birds within the flock, as 
well as from a number of vectors and fomites including workers and transportation 
equipment (Ramabu et al., 2004). Recent research has also indicated that vertical 
transmission from breeder to progeny flocks may also be a source of infection (Sahin et 
al., 2002). 
A highly attractive and potentially effective approach for the control of pathogens 
present in the intestinal tract is the administration of specific neutralizing antibodies in 
the diet (Berghman et al., 2005; Mine and Kovacs-Nolan, 2002). Egg-yolk from 
hyperimmunized laying hens has been shown to be an abundant and inexpensive source 
of antibodies (Mine and Kovacs-Nolan, 2002), especially compared to other sources. 
The use of HEA to control both bacterial and viral intestinal pathogens has been 
examined in various animal and avian species, however the results have been mixed.  
Several studies have reported that HEA specific for Escherichia coli protect pigs 
against challenges with enterotoxigenic E. coli (Imberechts et al., 1997; Marquardt et 
al., 1999; Wiedemann et al., 1991; Yokoyama et al., 1992). This protection has been 
shown to be particularly effective when colonization factors such as attachment 
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fimbriae were used to hyperimmunize the laying hens. Using purified F4 antigen to 
generate HEA Marquardt et al. (1999) and Wiedemann et al. (1991) demonstrated 
protection against enterotoxigenic F4+ E. coli in neonatal and early-weaned piglets. 
Similarily, using F18 antigen Yokoyama et al. (1997) and Imberechts et al. (1997) 
produced protective HEA to treat virulent F18+ E. coli.  In addition to protecting swine 
from E. coli infections, HEA have also been shown to be effective in reducing mortality 
in neonatal calves that were experimentally challenged with Salmonella typhimurium 
and Salmonella dublin (Yokoyama et al., 1998a). In contrast to these positive results 
however, Letellier et al. (2000) examined the use of HEA to control Salmonella 
typhimurium in swine with results that suggested there was no significant reduction in 
the infection of experimentally challenged pigs. Fulton et al. (2002) reported that ducks 
administered anti-Salmonella enteritidis in drinking water were partially protected 
against a S. enteritidis challenge, however full protection was conferred only with the 
co-administration of a probiotic. Kobayashi et al. (2004) found that that HEA were 
incapable of eliminating a Cryptosporidium parvum  infection in experimentally 
infected mice, and Kassaify and Mine (2004) recently demonstrated that both non-
immunized and immunized HEA confers the same level of protection to laying hens 
challenged with S. enteritidis. In addition to their ability to reduce the passage of S. 
enteritidis across the basolateral membrane in human epithelial cells (Sugita-Konishi et 
al., 2000), HEA have been shown to reduce mortality in rainbow trout from Yersinia 
ruckeri infections (Lee et al., 2000), as well as rotavirus infections in mice (Bartz et al., 
1980). The objective of the present study was to evaluate the ability of anti-S. enteritidis 
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and anti-C. jejuni specific HEA to reduce the number of these pathogens in the 
gastrointestinal tract of broiler chickens.  
4.3. Materials and Methods 
4.3.1. Bacteria and culture conditions 
A S. enteritidis isolate of chicken origin was obtained from Dr. Manuel Chirino, 
Dept. of Veterinary Microbiology, Western College of Veterinary Medicine, University 
of Saskatchewan, Saskatoon, SK Canada. The isolate was screened for both Nalidixic 
Acid (25µg/ml) and Novobiocin resistance (25µg/ml) (Nalr Novor), with the resulting 
isolate used for both antibody production and animal challenge studies. For C. jejuni 
antibody production and animal challenge studies, a Nalidixic Acid resistant (125µg/ml) 
Campylobacter jejuni (Nalr) isolate was obtained from Dr. Dianne Taylor, Dept. of 
Microbiology, University of Alberta, Edmonton, AB, Canada. The Salmonella 
enteritidis (Nalr Novor) isolate was grown aerobically in Trypticase Soy Broth (Difco) 
at 37ºC until late log phase (6 hour). For animal challenge studies, the cells were 
harvested by centrifugation (3640 x g for 15 min at 4ºC), washed twice and resuspended 
in phosphate buffered saline (PBS, pH 7.2) to a final titre of approximately 1.0 x 108 
CFU/mL. For bacterin production, the centrifuged cells were resuspended in PBS 
containing 0.06% formalin to a final titre of 1.0 x 109 CFU/mL. After resuspension in 
formalin, the cells were placed at 4°C for 1 week. Following 1 week at 4°C, the cells 
were centrifuged (3640 x g for 15 min at 4ºC) and resuspended in PBS containing 
0.05% sodium azide, stored at 4°C, and used for immunizing laying hens. The C. jejuni 
(Nalr) isolate was grown on blood agar plates containing 125µg/ml Nalidixic acid, 
aseptically scraped from plates, washed twice and resuspended in PBS as above. The 
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resuspended cells (108 CFU/mL) were used in animals challenge studies, or formalin 
killed as above, washed twice, and resuspended in PBS containing 0.05% sodium azide, 
stored at 4°C, and used for immunizing laying hens. 
4.3.2. Antibody Production 
A total of 8 commercial White Leghorn chickens were used for the production of 
antibodies. Four laying hens each were immunized with either the S. enteritidis or the 
C. jejuni bacterin produced as described above. The bacterin was emulsified with an 
equal volume of complete Freund’s adjuvant for the primary immunization, and 
Freund’s incomplete adjuvant for all subsequent booster immunizations. The 
immunization dose was approximately 1.0 x 109 CFU of killed S. enteritidis or C. jejuni 
in a volume of 1.0 mL equally divided between 2 intramuscular injection sites in the 
breast muscle. Hens were boosted every two weeks for a total of eight weeks until 
antibody titres failed to increase in collected eggs (as measured using enzyme-linked 
immunosorbent assay (ELISA), described below). Once high anti S. enteritidis and C. 
jejuni antibody titres had been established, eggs were collected and the yolks were 
separated, pooled, and stored at -20oC. 
4.3.3. Concentration and Preparation of Antibodies  
The hen-egg yolk antibodies were purified and concentrated using ammonium 
sulfate precipitation. Egg yolks were thawed and diluted 1:10 (w/v) using deionized 
water containing 0.02% Sodium Azide, and mixed well using a homogenizer (Polytron 
T45/2). The water egg yolk mixture was adjusted to pH 5.4 and placed at 4°C overnight. 
The next morning the supernatant was decanted and solid ammonium sulfate added to a 
give a final concentration of 25 % (w/v) and stirred for 30 min at room temperature. 
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The solution was centrifuged (3640 x g for 30 min at 4°C) with the resulting pellet 
resuspended in 100 mL PBS per litre of starting material. To the resuspended pellet 
25% (w/v) ammonium sulfate was added and stirred for 30 min at room temperature, 
centrifuged and the resulting pellet resuspended in a minimal amount of PBS. Finally, 
the resuspended pellet was dialized overnight at 4°C against 2 changes of PBS, and 
frozen. 
4.3.4. Measurement of Antibody Titres 
Egg antibody titres were measured using an enzyme-linked immunosorbent assay 
(ELISA). A 96 well microtitre plate (Immunlon 2, Dynatech Laboratories Inc., 
Chantilly, VA) was coated overnight at 4°C with either 106 CFU of S. enteritidis or C. 
jejuni suspended in PBS. The plate was washed 4x with PBS containing 0.05% Tween-
20 (PBS-T), after which 100 µL volumes of doubling dilutions of the samples were 
added. The microtitre plate containing the sample was then incubated at 37°C for 1 h. 
Following incubation the plate was washed 4x with PBS-T, and 100 µL of a horseradish 
peroxidase-conjugated mouse anti-chicken IgG antibody (Sigma) diluted 1/1000 with 
PBS-T was added and the plate was incubated at 37°C for 1 h. The plate was then 
washed 4x again with PBS-T and incubated for 15 min with 50 µL of a solution 
consisting of 1 mg/mL ABTS substrate (Boehringer Mannheim Biochemica, Germany). 
The absorbance of each well was determined at 450 nm using an automated 
spectophotometer (Molecular Devices, Vmax Kinetic microplate reader; Molecular 
Devices, Menlo Park, CA). Egg antibody titres were reported as the highest dilution in 
which the optical density (OD) was greater than the OD of the mean plus three standard 
errors (SE) of a series of control wells containing egg yolks obtained from normal 
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unimmunized hens. Antibody titres in feed and intestinal contents were determined as 
above with control wells containing PBS instead of normal egg yolk. 
4.3.5. Animal Protocols 
Experimental protocols were approved by the Animal Care Committee of the 
University of Saskatchewan and were performed in accordance with the 
recommendations of the Canadian Council on Animal Care (1993). Experimental birds 
were housed in heated battery cages and at the Animal Care Facility of the Western 
College of Veterinary Medicine, University of Saskatchewan, Saskatoon, SK. In each 
experiment, 30 mixed-sex day-of-hatch Ross 308 broiler chicks (Lilydale Hatchery, 
Wynyard SK) were used. Upon arrival birds were orally challenged with 0.5 mL of a 1 
x 109 CFU/mL culture of S. enteritidis for trials evaluating the anti-S. enteritidis HEA, 
or 0.5 mL of 1 x 108 CFU/mL culture of C. jejuni for trials evaluating the anti-C. jejuni 
HEA. Infected birds were subsequently placed into 2 cages, with 15 birds per cage, and 
provided both water and a non-medicated commercial starter crumble ad libitum (Co-op 
Feeds, Saskatoon, SK). To allow pathogen colonization birds were allowed to rest 3 
hours prior to antibody administration. 
4.3.5.1.  Experiment 1 (evaluation of in-feed administration) 
In experiments separately evaluating either the anti-S. enteritidis HEA or the anti-C. 
jejuni HEA, anti-S. enteritidis or anti-C. jejuni hen egg antibody yolk was added to the 
non-medicated starter crumble and mixed thoroughly to a final concentration of 0.5% 
(w/w). In each experiment the control group received feed containing egg antibodies 
from unimmunized laying hens at the same final concentration. To preserve antibody 
activity, the antibody amended feed was placed at 4ºC until just prior to use. On days 4, 
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7 and 11 post-challenge, 5 birds from each group were euthanized by cervical 
dislocation and the intestinal contents from the jejunum, ileum, and cecum collected for 
enumeration of either S. enteritidis or C. jejuni. 
4.3.5.2.  Experiment 2 (evaluation of low-antibody-titre gavage) 
In separate experiments evaluating each pathogen-specific HEA, birds in the 
treatment group were orally gavaged with 0.9 mL of either the non-concentrated anti-S. 
enteritidis HEA or anti-C. jejuni HEA, resuspended in PBS (PBS extracted) 3 hours 
post-infection. The control group received PBS extracted HEA from unimmunized 
hens.  Birds were gavaged daily for 7 consecutive days. On days 4, 7 and 11 post-
challenge, 5 birds from each group were euthanized by cervical dislocation and the 
intestinal contents from the jejunum, ileum, and cecum collected for enumeration of 
either S. enteritidis or C. jejuni. 
4.3.5.3.  Experiment 3 (evaluation of concentrated-antibody gavage) 
In separate experiments evaluating each pathogen-specific HEA, birds in the 
treatment group were orally gavaged with 0.9 mL of the ammonium-sulfate-precipitated 
anti-S. enteritidis HEA (10x concentrated) 3 hours post-infection. The control group 
received ammonium-sulfate-precipitated HEA from unimmunized hens.  Birds were 
gavaged daily for 7 consecutive days. On days 4, 7 and 11 post-challenge, 5 birds from 
each group were euthanized by cervical dislocation and the intestinal contents from the 
jejunum, ileum, and cecum collected for enumeration of either S. enteritidis or C. jejuni. 
4.3.6. Sample collection and pathogen enumeration 
In all experiments, the entire contents of the jejunum, ileum, and cecae were 
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separately removed from each bird. The collected contents from each intestinal location 
was then mixed thoroughly and a subsample of each was placed in sterile peptone 
containing 0.5% cysteine hydrochloride and immediately placed on ice. The subsamples 
were serially diluted and plated in duplicate using an automated spiral plater (Autoplate, 
Spiral Biotech Inc., Bethesda MD, USA). For the enumeration of C. jejuni samples 
were plated on Modified Preston’s Campylobacter Isolation Agar (Oxoid) containing 
125µg/mL Nalidixic acid (Sigma) and incubated at 37°C for 48 hours in the appropriate 
atmospheric conditions (BBL271045 Campy-Pac; Becton Dickinson Microbiology 
Systems). Enumeration of S. enteritidis was done using Brilliant Green Agar (Difco) 
containing 25 µg/mL of Nalidixic acid and Novobiocin (Sigma), incubated for 16 hours 
aerobically. Statistical analyses of the log10 transformed CFU was performed using 
SPSS (v.10.0.5, SPSS Inc, Chicago IL, USA). 
4.3.7. In vitro adhesion assay 
To evaluate the ability of the HEAs to inhibit pathogen attachment to epithelial cells 
and mucin, an actively growing culture of S. enteritidis was harvested, centrifuged and 
then resuspended in thymidine-free media containing 1% [methyl, 1,2-3H]thymidine 
(Amersham International, UK) (total activity 10µC/mL) and incubated aerobically at 
37ºC for 9 hours. The 3H-labeled S. enteritidis culture was washed twice, resuspended 
in HEPES-Hanks buffer, and incubated in the presence of doubling dilutions of anti-S. 
enteritidis HEA  for 1 hour. Unbound antibody was removed by centrifugation and the 
antibody-coated cells were resuspended in HEPES-Hanks buffer. 1.0 mL of the 
resuspended cells were then dispensed in triplicate into 24 well sterile sterile tissue 
culture plates (Nunc) that had been coated with either rat small intestine epithelial cells 
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grown to confluency (cell line IEL-18, ATTC, Rockwell, Maryland, USA), or 1.0% 
porcine mucin in PBS. Both the mucin and epithelial cell coated plates were washed 
twice with HEPES-Hanks buffer prior to the addition of radiolabeled bacteria. The 
bacteria were incubated in the tissue culture plates for 1 hour at 37°C. For the effect of 
HEA on the ability of C. jejuni to attach to mucin, harvested cells were treated identical 
to the S. enteritidis except incubation was done in a 1L anaerobic jar (Becton Dickinson 
Microbiology Systems) containing atmospheric conditions for growth of C. jejuni 
(BBL271045 Campy-Pac; Becton Dickinson Microbiology Systems), and the resulting 
radiolabelled C. jejuni  were incubated in the mucin coated plates for 3 hours. In all 
cases, non-attached microbes were removed after 1 hour by rinsing plates twice with 
HEPES-Hanks buffer, and the attached microbes were removed from the enterocytes 
and mucin by 24 hour incubation in 5% SDS. 100µL of the contents of each well was 
recovered, placed in scintillation vials and the radioactivity counted using a Beckman 
LS6000TA Scintillation Counter. 
4.3.8. Specific antibody intestinal activity assay 
An enzyme-linked immunosorbent assay (ELISA) was used to measure the specific 
anti-S. enteritidis HEA in the intestinal tract. Four day-of-hatch chicks were orally 
gavaged with 0.9 mL of the non-concentrated, PBS-extracted anti-S. enteritidis HEA, or 
PBS as a negative control. At 1 and 3 hours post administration, 2 birds from each 
group were euthanized by cervical dislocation. Intestinal contents were obtained by 
excising and gently rinsing 3cm sections of the jejunum, ileum, and cecum with 1.0 mL 
enzyme inhibitor solution, and placed into ependorf centrifuge tubes on ice. The 
composition of the enzyme inhibitor was as follows; 0.15 M NaCl, 0.005 M NaH2PO4-
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H2O, 0.005 M Na2HPO4, 0.02% sodium azide, 5 mM EDTA-Na2, 2 mM 
phenylmethylsulfonyl fluoride, 10 U/mL aprotinin. The ependorf tubes containing the 
intestinal washes were then vigorously vortexed, centrifuged at 5,000 x g for 10 min at 
4°C and the supernatant removed. 100µL of the supernatant containing the HEA was 
then dispensed into a 96 well microtitre plate (Immunlon 2, Dynatech Laboratories Inc., 
Chantilly, VA) that had been coated overnight at 4°C with 106 CFU of either S. 
enteritidis in PBS, and washed with PBS buffer containing 0.05% Tween-20 (PBS-T). 
The microtitre plate containing the intestinal washes was incubated at 37°C for 1 hour, 
washed with PBS-T, and a horshradish peroxidase-conjugated mouse anti-chicken IgG 
antibody (Sigma) diluted 1/1000 with PBS-T. The wells were washed with PBS-T and 
incubated with 50µL of a solution consisting of 1 mg/mL of ABTS substrate 
(Boehringer Mannheim Biochemica, Germany). The absorbance of each well was 
determined at 450 nm using an automated spectophotometer (Molecular Devices, Vmax 
Kinetic microplate reader; Molecular Devices, Menlo Park, CA). Antibody activity was 
reported as the mean optical density (OD) readings from two birds, after the subtraction 
of the OD of the mean of a series of 6 control wells containing PBS as a control. 
4.4. Results 
The anti-S. enteritidis and anti-C. jejuni HEA endpoint titres from the 
hyperimmunized hens plateaued at 1: 256,000 and 1:128,000, respectively. Following 
overnight extraction using PBS at pH 5.6, the antibody titres were slightly less than 1/10 
the titre found in the egg yolks and was determined to be 1:16,000 and 1:8,000. After 
ammonium sulfate precipitation the HEA titres were both determined to be 1:100,000. 
The ability of the HEA to inhibit attachment of S. enteritidis to intestinal enterocytes 
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and mucin was evaluated in vitro using rat epithelial cells (Figure 4.1) and porcine 
mucin (Figure 4.2). Compared to the negative control where no antibody was added to  
the radiolabeled S. enteritidis, the anti-S. enteritidis HEA was able to inhibit the 
attachment to the rat epithelial cells at all dilutions. The addition of antibody at all 
dilutions reduced the CPM from 154 ± 20 for the no antibody control (PBS extracted 
alone), to 42 ± 2 for the 1:16,000 dilution, 59 ± 21 for the 1:32,000 dilution, 83 ± 15 for 
the 1:64,000 dilution, 58 ± 14 for the 1:128,000, 52 ± 12 for the 1:256,000, and finally 
32 ± 15 for the antibody when diluted to 1:512,000. The addition of anti-S. enteritidis 
HEA to the radiolabeled S. enteritidis however, appeared to increase the ability of S. 
enteritidis to attach to mucin. Compared to the no antibody control with CPM of 556 ± 
49, the addition of the purified, non-concentrated HEA resulted in an increase to 1850 ± 
428. As the HEA was diluted the ability of S. enteritidis to become associated with the 
mucin also appeared to diminish. 
The addition of anti-C. jejuni HEA to C. jejuni, however, resulted in a decrease in 
the ability of the pathogen to attach to the mucin in vitro (Figure 4.3). In the absence of 
antibody, the radiolabeled C. jejuni alone resulted in a CPM of 314 ± 69, whereas 
incubation in the presence of doubling dilutions of pathogen-specific HEA from 
1:16,000 to 1:256,000 resulted in a reduction in the CPM.   
When administered to day old chicks, the HEA was shown to be active in the 
intestinal tract up to 3 hours post administration (Figure 4.4). The mean ODs from the 
intestinal washes obtained from birds euthanized at 1 and 3 hours after oral 
administration of the PBS extracted anti-S. enteritidis antibody resulted in detectable 
activity above background at both time points and in all locations. At 1 hour post  
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Figure 4.1. 3H-labeled S. enteritidis bound to rat epithelial cell line IEL-6 after 
incubation for one hour in wells containing anti-S. enteritidis HEA. Bars are the 
mean CPM ± standard deviation of 3 wells.
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Figure 4.2. 3H-labeled S. enteritidis bound to porcine mucin after incubation for 
one hour in wells containing anti-S. enteritidis HEA. Bars are the mean CPM ± 
standard deviation of 3 wells. 
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Figure 4.3. 3H-labeled C. jejuni bound to porcine mucin after incubation for one 
hour in wells containing anti- C. jejuni HEA. Bars are the mean CPM ± standard 
deviation of 3 wells. 
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Figure 4.4. Relative intestinal HEA activity in day-of-hatch broiler chicks orally 
gavaged with anti-S. enteritidis PBS extracted antibody at 1 and 3 hours post-
gavage. The Bars at each intestinal location represent the mean O.D. value of 2 
birds.  
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administration, the relative ODs were 0.265, 0.571, and 0.160 for the jejunum, ileum, 
and cecum, compared to 0.175, 0.121, and 0.000 for the PBS gavaged negative 
control,respectively. At 3 hours post-administration, detectable antibody was observed, 
albeit at lower levels than the previous sampling time. Compared to the OD values 
obtained from birds administered PBS of 0.071, 0.030, and 0.006 for the jejunum, 
ileum, and cecum, birds administered the pathogen specific HEA antibody had ODs of 
0.085, 0.120, 0.168, respectively. 
Despite measurable antibody activity of the HEA in the jejunum, ileum, and cecum 
of chicks, the administration of anti-S. enteritidis and anti-C. jejuni HEA in the diet 
(Figures 4.5 and 4.6), or gavaged at either the non-concentrated (Figures 4.7 and 4.8) or 
concentrated titres (Figures 4.9 and 4.10), did not significantly reduce (P < 0.05) the 
level of intestinal colonization by either pathogen. This observation was true for any 
time point or intestinal location, while the observed level of colonization of both S. 
enteritidis and C. jejuni was consistent with colonization levels observed using this 
challenge model in previous trials. 
4.5. Discussion 
Immunization of laying hens resulted in antibody titres that were consistent with, or 
exceeded titres obtained by other researchers (Marquardt et al., 1999). The PBS 
precipitated HEA resulted in the lowest titre of 1:16,000, however even at this titre there 
was measurable antibody activity when experimental day-of-hatch birds were orally 
gavaged. Measured by ELISA, the in vivo passage of antibody was confirmed (Figure 
4.4) with continued functionality of the antibody as it transited the intestinal tract. 
Although the highest level of activity was shown to be in the ileum after 1 hour, activity  
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Figure 4.5. Intestinal counts on days 4 (A), 7 (B), and 11 (C) of broiler chicks 
challenged with S. enteritidis and fed anti-S. enteritidis HEA amended feed. Bars 
represent mean ± standard deviation (N=5).
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Figure 4.6. Intestinal counts on days 4 (A), 7 (B), and 11 (C) of broiler chicks 
challenged with C. jejuni and fed anti-C. jejuni HEA amended feed. Bars represent 
mean ± standard deviation (N=5).
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Figure 4.7. Intestinal counts on days 4 (A), 7 (B), and 11 (C) of broiler chicks 
challenged with S. enteritidis and daily orally gavaged with PBS extracted anti-S. 
enteritidis HEA for 7 days. Bars represent mean ± standard deviation (N=5).
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Figure 4.8. Intestinal counts on days 4 (A), 7 (B), and 11 (C) of broiler chicks 
challenged with C. jejuni and daily orally gavaged with PBS extracted anti-C. 
jejuni HEA for 7 days. Bars represent mean ± standard deviation (N=5).
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Figure 4.9. Intestinal counts at days 4 (A), 7 (B), and 11 (C) of broiler chicks 
challenged with S. enteritidis and daily orally gavaged with ammonium sulfate 
precipitated anti-S. enteritidis HEA for 7 days. Bars represent mean ± standard 
deviation (N=5).
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Figure 4.10. Intestinal counts on days 4 (A), 7 (B), and 11 (C) of broiler chicks 
challenged with C. jejuni and daily orally gavaged with ammonium sulfate 
precipitated anti- C. jejuni HEA for 7 days. Bars represent mean ± standard 
deviation (N=5). 
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was still present after 3 hours. Interestingly, there was measurable antibody activity in 
the cecum which possesses the highest number of intestinal microorganisms. The 
observation that administered antibody retains activity in the intestinal tract agrees with 
results obtained for other animal species including pigs (Yokoyama et al., 1993) and 
rainbow trout (Lee et al., 2000). As with these other studies, we administered the 
antibody as a single bolus dose. The dynamics of a single bolus administration would be 
different than administration of antibody over a longer period of time, as it would be the 
case if the antibody mixed with feed. The constant administration in feed would result 
in stable activity in each compartment, which would be required for prophylaxis or 
therapy. In this trial we administered the antibody to day-of-hatch chicks, however it is 
unclear if the antibody activity would be similar or reduced in more mature birds with a 
more developed digestive capacity and intestinal microflora. 
By administering hyperimmunized egg yolk in the feed, the extraction of HEA from 
yolks using PBS, and further concentration using ammonium sulfate, we were able to 
evaluate 3 different regimes for the administration of each pathogen-specific antibody. 
To determine if the constant administration of native antibody, with the potentially 
protective yolk, would be better able to provide protection than orally gavaged HEA, 
both anti-C. jejuni and anti-S. enteritidis HEA were mixed in feed at 0.5% (w/w) for 
experiment 1. In experiments 2 and 3 however, the experimental birds were orally 
gavaged with the PBS extracted and concentrated HEA, respectively. Regardless of the 
route of administration, there was no significant (P < 0.05) reduction in the intestinal 
colonization of either S. enteritidis or C. jejuni, compared to the negative controls. 
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Despite the negative results obtained in vivo, anti-S. enteriditis HEA was able to 
reduce the ability of S. enteritidis to colonize rat enterocytes in vitro. The observed 
attachment inhibition might contribute to a shorter infection period in challenged birds, 
however it is not clear whether intestinal colonization would be affected during this 2 
week experimental period. For pathogens with a Type III secretion system such as 
Salmonella spp. (Mota and Cornelis, 2005), colonization of intestinal surfaces may be a 
contributing factor for translocation and ultimately the persistence of the infection, 
however the colonization of mucus and intestinal contents, particularly in the ileum and 
cecae, may occur independently. The incubation of S. enteritidis in the presence of anti- 
S. enteritidis HEA did not decrease, but rather increased, the ability of S. enteritidis to 
become associated with porcine mucin (Figure 4.2). The conditions observed in the 
intestinal tract are more complex than the in vitro system using porcine mucin, 
however, the observed increase in the ability of S. enteritidis to become associated with 
mucin in the presence of anti-S. enteritidis HEA may have contributed to the lack of 
intestinal clearing even in the absence of epithelial surface attachment. Other 
researchers have reported an increase in the infection rate among Salmonella-challenged 
birds fed anti-Salmonella HEA (Fulton et al., 2002). The authors attributed this 
increased rate of infection to antibody-mediated opsonization of Salmonella. In this 
study we did not examine the translocation of S. enteritidis to other organs, but clearly 
translocation may have contributed to persistent shedding and a lack of any observed 
reduction regardless of the route of HEA administration. 
The in vitro attachment of C. jejuni to the rat epithelial cells was impossible to 
demonstrate as the growth conditions for C. jejuni was different than those required for 
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the maintenance of the cell lines. The particular growth requirements for C. jejuni, 
which prefers a solid surface on which to grow, and thus difficult to label with tritiated 
thymidine, also resulted in considerably lower CPM values for this pathogen compared 
to S. enteritidis (Figure 4.3). However, even with lower CPM values it was possible to 
demonstrate an effect of HEA on mucin attachment by C. jejuni. Whereas incubation 
with anti-S. enteritidis HEA increased ability of S. enteritidis to become associated with 
the mucin in vitro, incubation of C. jejuni with anti-C. jejuni HEA resulted in a decrease 
in CPMs compared to the negative control. This finding is consistent with research done 
by others. In addition to forming a protective barrier overlying the intestinal surface, 
intestinal mucin also supports the growth of a number of intestinal bacteria including 
both commensal and pathogenic microorganisms such as C. jejuni (Fernandez et al., 
2000; Sylvester et al., 1996), and it would appear that the presence of anti-C. jejuni 
HEA reduced the ability of C. jejuni to become associated with mucin in vitro.  
Other researchers have shown negative results using HEA raised against bacterins 
(Fulton et al., 2002) and also Cryptosporidium parvum oocysts (Kobayashi et al., 
2004). Kobayashi et al. (2004) suggested that using specific oocyst surface proteins 
may serve to increase the efficacy of HEA. This may be the case as they appear to be 
most effective when they target specific virulence factors such as attachment fimbria of 
E. coli (Imberechts et al., 1997; Yokoyama et al., 1997), or outer membrane proteins of 
Salmonella spp. (Yokoyama et al., 1998a). In addition to increasing the specificity of 
antibodies by vaccinating hens with pathogen-specific virulence factors, other 
researchers have successfully examined using protected antibodies to improve intestinal 
activity of orally administered HEA (Kovacs-Nolan and Mine, 2005). Although we did 
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not attempt to protect the antibody, some sort of antibody protection might enable the 
antibody to transit the crop, stomach, and proximal intestine where conditions are most 
harsh. This might increase its survivability and ultimately make it more efficacious. 
Thus, despite measurable activity of both anti-S. enteritidis and anti-C. Jejuni HEA 
in vitro, using our challenge model they did not reduce the intestinal colonization of 
broiler chicks in vivo. It can be concluded therefore, that although HEA show promise 
as a prophylactic strategy for the reduction of pathogenic microorganisms, more work is 
needed to understand the pathogenic determinants which may result in effective 
antibody activity in vivo and in vivo, as well as the intestinal conditions which reduce 
their efficacy. 
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5. THE EFFECT OF HEN-EGG ANTIBODIES ON CLOSTRIDIUM 
PERFRINGENS COLONIZATION IN THE GASTROINTESTINAL TRACT 
OF BROILER CHICKENS 
 
5.1. Abstract 
We evaluated the ability of hen-egg antibodies (HEA) to reduce intestinal 
colonization by Clostridium perfringens in broiler chickens. Antibodies against C. 
perfringens or cholera toxin (negative control) were obtained from the eggs of laying 
hens hyperimmunized using a C. perfringens bacterin or cholera toxin. Eggs were 
collected, pooled, and egg antibodies were concentrated by polyethylene-glycol 
precipitation. An initial experiment was conducted to determine the in vivo activity of 
the administered antibody along the length of the intestine. Thereafter, two feeding 
trials were performed to assess the efficacy of feed amended with the egg antibodies in 
reducing the level of colonization of C. perfringens in challenged birds. Antibody 
activity declined from proximal to distal regions of the intestine but remained detectable 
in the cecum. In the first experiment there was no significant reduction in the number of 
C. perfringens in the birds fed the diet amended with the anti-C. perfringens egg 
antibody, compared to the birds that received the anti-cholera toxin egg antibody (n = 
10), at any of the sampling times. In the second experiment there was a significant 
decrease in C. perfringens intestinal populations 72 hours after treatment (n = 15) as 
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assessed by culture-based enumeration, but there was no decrease as measured by 
quantitative PCR based on the C. perfringens phospholipase C gene. Intestinal-lesion 
scores were higher in the birds that received the anti- C. perfringens HEA. Our work 
suggests that administration of HEA did not reduce the level of C. perfringens intestinal 
colonization and conversely might exacerbate necrotic enteritis. 
5.2. Introduction 
Intestinal pathogens result in economically important losses to poultry producers 
annually. Clostridium perfringens, the causative agent of necrotic enteritis (NE), is one 
such pathogen. Presently, the incidence of NE is effectively controlled through the use 
of antibiotic feed additives; however their outright ban in Europe, as well as consumer 
concerns in North America, has led to an increased interest in alternatives for the 
control of intestinal pathogens. The use of orally administered antibodies to control both 
bacterial and viral intestinal pathogens has been examined in various animal and avian 
species, with mixed results.  
Some studies reported that pathogen-specific HEA can confer protection to pigs 
experimentally challenged with enterotoxigenic E. coli (Imberechts et al., 1997; 
Marquardt et al., 1999; Wiedemann et al., 1991; Yokoyama et al., 1997; Yokoyama et 
al., 1992), neonatal calves experimentally challenged with Salmonella typhimurium and 
Salmonella dublin (Yokoyama et al., 1998a), rainbow trout from Yersinia ruckeri 
infections (Lee et al., 2000), and rotavirus infections in mice (Bartz et al., 1980). In 
contrast to these positive results however, Fulton et al. (2002) reported that ducks 
administered anti-Salmonella enteritidis antibodies in drinking water were only partially 
protected against a S. enteritidis challenge, and Letellier et al. (2000) examined the use 
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of HEA to control Salmonella typhimurium in swine with results that suggested there 
was no significant reduction in the infection of experimentally challenged pigs. 
Kobayashi et al. (2004) found that that HEA were incapable of eliminating a 
Cryptosporidium parvum  infection in experimentally infected mice, and Kassaify and 
Mine (2004) recently demonstrated that HEA from non-immunized hens confer the 
same level of protection to laying hens when challenged with S. enteritidis as HEA 
from hens immunized against S. enteritidis. 
The use of specific HEA to reduce C. perfringens colonization in the intestinal tract 
of broiler chickens, however, has not been fully explored. We evaluated the ability of 
anti-C. perfringens specific HEA to decrease the number of C. perfringens cells in the 
gastrointestinal tract of broiler chickens, and thereby reduce an important predisposing 
factor for the development of NE. 
5.3. Materials and Methods 
5.3.1. Bacteria and culture conditions 
A C. perfringens Type A isolate isolated from a field case of necrotic enteritis was 
obtained from Dr. Manuel Chirino, Dept. of Veterinary Microbiology, Western College 
of Veterinary Medicine, University of Saskatchewan, Saskatoon, SK., Canada. To 
ensure maximum viability of cultures the bacteria were grown in Brain Heart Infusion 
(Difco) anaerobically at 37°C until late log phase. For bacterin production the cells were 
harvested by centrifugation (3640 x g for 15 min at 4ºC), washed twice in phosphate-
buffered saline (PBS, pH 7.2), and resuspended in phosphate-buffered saline containing 
0.06% formalin. After resuspension in formalin the cells were placed at 4°C for 1 week 
prior to use.  
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5.3.2. Antibody preparation 
The hyperimmunization of laying hens was conducted from January to May 2004 in 
the Poultry Centre at the University of Saskatchewan. Four commercial White Leghorn 
chickens were immunized with the C. perfringens bacterin produced as described 
above. The bacterin was emulsified with an equal volume of complete Freund’s 
adjuvant for the first immunization, and Freund’s incomplete adjuvant for all 
subsequent boosters. The immunization dose was approximately 1.0 X 109 CFU of 
killed C. perfringens in a volume of 1.0 mL equally divided between two injection sites. 
Another four hens were immunized with 1.0 mL of a cholera toxin (CTX) solution 
suspended in sterile PBS (10.0 µg/mL). Hens were boosted every 2 weeks for a total of 
8 weeks until antibody titres failed to increase in collected eggs (as measured using 
enzyme-linked immunosorbent assay (ELISA), described below). Once high anti-C. 
perfringens and anti-CTX antibody titres had been established, eggs were collected and 
the yolks were separated and pooled. The pooled egg yolks were then diluted 1:6 in 
distilled water and polyethylene glycol (8000 molecular weight) (PEG) was added to 
give a final concentration of 30 g/kg of PEG.  The resulting mixture was stirred at 4oC 
for 30 min and then centrifuged at 3640 x g for 15 min at 4oC. The supernatant was 
recovered and PEG was added to give a final concentration of 120 g/Kg. The mixture 
was then stirred at 4oC for 30 min followed by centrifugation at 3640 x g for 15 min at 
4oC. The precipitate was recovered, resuspended in a minimal amount of PBS, and 
frozen.  
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5.3.3. Measurement of antibody activity 
Egg-antibody titres were measured using an ELISA. Briefly, a 96-well microtitre 
plate (Immunlon 2, Dynatech Laboratories Inc., Chantilly, VA) was coated overnight at 
4°C with either 106 CFUs of C. perfringens or 10.0 µg/mL CTX suspended in PBS. The 
plate was washed 4X with PBS containing 0.05% Tween-20 (PBS-T), and 100 µL 
volumes of doubling dilutions of the samples were added. The microtitre plate 
containing the sample was then incubated at 37°C for 1 h. Following incubation the 
plate was washed 4X with PBS-T, and 100 µL of a horseradish peroxidase-conjugated 
mouse anti-chicken IgG antibody (Sigma) diluted 1/1000 with PBS-T was added and 
the plate was incubated at 37°C for 1 h. The plate was then washed again with PBS-T 
and incubated for 15 min with 50 µL of a solution consisting of 1 mg/mL ABTS 
substrate (Boehringer Mannheim Biochemica, Germany). The absorbance of each well 
was determined at 450 nm using an automated spectophotometer (Molecular Devices, 
Vmax Kinetic microplate reader; Molecular Devices, Menlo Park, CA). Titres were 
reported as the highest dilution in which the optical density (OD) was greater than the 
OD of the mean plus three standard errors (SE) of a series of control wells containing 
egg yolks obtained from normal unimmunized hens. Antibody titres in feed and 
intestinal contents were determined as above with control wells containing PBS instead 
of normal egg yolk. 
5.3.4. Experimental diets 
A high-protein diet (Table 5.1) previously shown to encourage intestinal 
colonization by C. perfringens was used (Drew et al., 2004; Wilkie et al., 2005). The 
PEG-precipitated anti- C. perfringens or anti-CTX HEA was added to the feed at 0.05  
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Table 5.1. Experimental diet used for all birds from days 14-281. 
 
5.0Vitamin/Mineral premix2
1.0Choline chloride
17.0Canola oil
16.0Limestone
220.0Wheat
411.6Corn
329.4Fish meal
g kg-1Ingredient
 
Footnote to Table 5.1 
1Diet was formulated to contain 315 g/kg crude protein and meet NRC requirements for broiler chickens. 
2Supplied per kilogram of diet: vitamin A, 3.3 mg; cholecalciferol, 55 μg; vitamin E, 30 mg; vitamin K, 
0.5 mg; vitamin B12; 0.02 mg; thiamine, 1.5 mg; riboflavin, 6 mg; folic acid, 0.6 mg; biotin, 0.15 mg; 
niacin, 60 mg; pyridoxine, 5 mg; 400 mg; chloride, 788 mg; sodium, 511 mg; iron, 80 mg;  manganese, 
21.8 mg; selenium, 0.1 mg; iodine, 0.35 mg; zinc, 100 mg. 
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and 0.065% (v/w) respectively, which provided the same amount of additional protein. 
The protein concentrations of the PEG precipitated anti- C. perfringens and anti-CTX 
HEA were determined using the Leco FP-528 Protein Analyzer (Leco Corporation St. 
Joseph MI, U.S.A.) and were 3.44 and 2.65% protein, respectively. Thus, the exogenous 
protein that was added to both diets from the HEA was 1.7 g/kg. For incorporation into 
feed, the HEA preparation was sprayed on the feed while mixing. The HEA feed was 
then stored at 4°C and removed immediately prior to use. 
5.3.5. Birds and infection  
Two in vivo experiments were carried out using day-of-hatch Ross 308 broiler 
chicks between September 2004 until January 2005 at the Animal Care Facility of the 
Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon SK, 
Canada. Experimental protocols were approved by the Animal Care Committee of the 
University of Saskatchewan and were performed in accordance with the 
recommendations of the Canadian Council on Animal Care as specified in the Guide to 
the Care and Use of Experimental Animals (Canadian Council on Animal Care, 1993). 
In both in vivo experiments 1 and 2, birds were challenged with the C. perfringens 
isolate described above. Based on results obtained from previous trials, our challenge 
model consists of orally gavaging chicks at day-of-hatch with 0.5 mL, and then again 
for 7 consecutive days from days 14 to 21 with 1.0 mL, of a late log phase culture (108 
CFU/mL). This infection protocol has proven to result in experimentally infected birds 
which are consistently and uniformly colonized with C. perfringens with similar, albeit 
less severe, mortality and morbidity typically observed in field cases of NE (Wilkie et 
al., 2005). After initial gavage, birds were placed into 1 of 2 battery cages, and provided 
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a nonmedicated commercial starter crumble ad libitum (Co-op Feeds, Saskatoon, SK). 
At 14 days after hatch, the birds were divided into groups of 15 birds per cage, and fed 
the non-HEA amended experimental diet. This diet was fed to all birds ad libitum until 
day 28. The birds were orally gavaged daily, with 1.0 mL of a C. perfringens culture 
from days 14 through 21 as described above. On day 28 half of the groups were fed the 
diet that had been amended with anti-CTX, while the other half the diet amended with 
the anti-C. perfringens HEA. At 0, 24, and 72 hours after switching to the HEA-diets, 
five birds from each cage were euthanized by cervical dislocation and samples of ileal 
and cecal digesta were taken for the enumeration of C. perfringens. In experiment 1, a 
total of 60 chicks were used for a total of 4 groups of 15 birds each. To increase the 
statistical power, in experiment 2 a total of 90 chicks were used for a total of 6 groups 
of 15 birds each. In experiment 2 the entire excised intestinal tracts of the birds were 
removed and examined macroscopically for the presence of lesions. A lesion score was 
assigned, via a blind study, for each bird based on a scale from 0 to 4 (0 = normal; 1 = 1 
to 5 small red petechiae; 2 > 5 small red petechiae; 3 = presence of focal necrotic 
lesions; and 4 = presence of patches of necrosis (1-2 cm long)). Micrographs of caecal-
tonsil cross-sections showing hemorrhagic lesions were obtained using 6-µm-thick 
hemotoxylin- and eosin-stained, formalin-fixed tissue using a Axiostar plus Zeiss 
microscope (Carl Zeiss Vision GmbH, Germany) fitted with Axiocam MRc camera. 
5.3.6. In vivo antibody activity assay 
The anti-CTX antibody titres present along the length of the intestinal tract were 
measured using 10 Ross 308 broiler chickens at 28 days of age. Birds were raised as 
above but were not challenged with C. perfringens. The HEA-amended experimental 
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diet was fed ad libitum for 48 hours and the birds were then euthanised by cervical 
dislocation and the entire gastrointestinal tract of the chicken was excised. Intestinal 
contents were collected from each of the crop, duodenum, jejunum, ileum, and cecum. 
A small subsample from each of the sections was diluted 1:10 in an enzyme inhibitor 
solution and immediately placed on ice. The composition of the enzyme inhibitor was 
as follows; 0.15 M NaCl, 0.005 M NaH2PO4-H2O, 0.005 M Na2HPO4, 0.02% sodium 
azide, 5 mM EDTA-Na2, 2 mM PMSF, 10 U/mL aprotinin. The diet and intestinal 
samples were then diluted in a microtitre plate using doubling dilutions of PBS, and the 
antibody activity determined by ELISA as described above. 
5.3.7. Sample collection and pathogen enumeration 
In both experiment 1 and 2, the entire contents of the ileum from Meckel’s 
diverticulum to the ileal-cecal junction, and the contents of both cecae were carefully 
removed from each bird. The collected contents were then mixed thoroughly and a 
subsample of each was placed in sterile peptone containing 0.5% cysteine hydrochloride 
and immediately placed on ice. For the enumeration of C. perfringens the subsamples 
were serially diluted and plated in duplicate using an automated spiral plater (Autoplate, 
Spiral Biotech Inc., Bethesda MD, USA) on BBL™ Blood Agar Base (Becton, 
Dickinson and Co., Sparks, MD, USA) containing 5.0% sheep blood and 0.01% 
Neomycin Sulfate (BAneo+) (The Upjohn Company, Orangeville, ON, Canada) The 
BAneo+ plates were incubated anaerobically for 24 hours at 37°C. Colonies exhibiting a 
double zone of hemolysis on the BAneo+ were counted as C. perfringens. Several 
presumptive colonies were picked, Gram stained, and examined microscopically to 
verify them as C. perfringens. 
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5.3.8. DNA extraction and molecular enumeration of C. perfringens in ileal 
digesta 
Samples (0.25g) of ileal contents were placed in a bead beating tube (Mo-Bio 
Laboratories, Solano Beach, CA) along with RNase A (75 µg), lysozyme (750 µg), and 
proteinase K (400 µg) in 0.6 ml of a buffer containing Triton X-100 (0.5%) and Tween 
80 (0.5%) (Qiagen genomic DNA buffer kit). Guanidine-HCl (675 mM) and Tween 20 
(4%) were then added and the samples were incubated at 50°C for 30 min. The samples 
were subjected to one freeze-thaw cycle at -70°C/25°C, then placed in a bead beater 
(Bio101 ThermoSavant FP120) and shaken for 20 sec (setting 5) in the presence of 1 
vol of 25:24:1 phenol:chloroform:isoamyl alcohol (Sigma). The tubes were centrifuged 
at 13,000 g for 15 min, the aqueous phase was placed in a new tube, and nucleic acids 
were precipitated with 1 volume isopropanol. The pellet was washed once with 70% 
ethanol, dried, and dissolved in 0.1 ml of TE buffer (10 mM Tris-Cl, 1 mM EDTA, pH 
8.0). 
PCR primers (5’- CTGGGGTATCAACTAAAGTCTACGC-3’ and 5’- 
CCTTTGCTGCATAATCCCAATC-3’) were designed to amplify a 693 base pair (bp) 
fragment (PLC-A) of the C. perfringens alpha toxin gene (GenBank accession number 
X17300). These primers (500 nM each) were used in a PCR containing C. perfringens 
genomic DNA (40 ng), 1.5 mM MgCl2, 0.2 mM each dNTP, and 1 U Taq DNA 
polymerase (Invitrogen) under the following conditions: 94°C, 4 min followed 
immediately by 40 cycles of 94°C, 1 min; 55°C, 1 min; 72°C, 1 min. The PCR product 
was purified on an agarose gel and incubated with 1 U Taq polymerase (Invitrogen) and 
0.2 mM each dNTP at 72°C for 15 min, then purified using a QiaQuick PCR 
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purification column (Qiagen). Purified PCR products were ligated into pGEM-T Easy 
(Promega) overnight at 4°C and the ligation mixture was used to transform E. coli 
JM109 (Promega). A single insert-containing clone was retrieved and used as a PCR 
standard as described below. 
A second set of alpha toxin-specific PCR primers was designed for molecular 
enumeration of C. perfringens using real-time quantitative PCR (qPCR). These primers 
(5’- GAAGCTATGCACTATTTTGGAGAT-3’ and 5’- 
ATACTGTTCTTTCCTTTCTTCTGC-3’) amplified a 120-bp fragment (PLC-B) of the 
C. perfringens alpha toxin gene that was nested within the larger cloned PLC-A 
fragment. To enumerate C. perfringens in ileal digesta samples, we first optimized the 
dilution of the DNA extracts to mitigate the effects of PCR inhibition (Dumonceaux et 
al., 2005) . DNA extracts were diluted 1:16 in TE buffer (10 mM Tris-Cl pH 8.0, 1 mM 
EDTA) and used in a qPCR assay along with standards consisting of known amounts of 
PLC-A plasmid DNA. Plasmid standards were expressed as copy number per qPCR 
assay, which was calculated as the weight of plasmid DNA in each standard divided by 
the plasmid molecular weight ( 2.4 x 106 g/mol based on a plasmid size of 3697 bp). 
qPCR assays used Platinum® SYBR Green Quantitative PCR SuperMix-UDG 
(Invitrogen) and included 3 mM MgCl2 and 500 nM each primer. Amplifications were 
preceeded by the following steps: 50°C, 2 min (UDG activation), then 95°C, 3 min 
(well factor collection); this was followed immediately by 40 cycles of 94°C, 30 sec; 
55°C, 30 sec; 72°C, 30 sec. Data collection was set at the extension step. Amplifications 
were performed using an iCycler (BioRad). qPCR counts were converted to genomes 
detected/g digesta based on the weight of digesta extracted and the dilution factors. 
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5.3.9. Determination of Phospholipase C activity in intestinal contents 
The alpha toxin activity from the intestinal contents of birds euthanized at hour 72 
of experiment 2 was investigated using Amplex Red PC-PLC assay kit (Molecular 
Probes, Eugene OR, USA) according to the manufacturer’s instructions. Briefly, 1.0 g 
of odd-numbered ileal samples from each group (six birds in each of the anti-C. 
perfringens and anti-CTX groups) were diluted 1:1 in the enzyme-inhibitor solution 
described above. Samples were then vortexed vigorously, centrifuged at 10,000g for 3 
min, decanted and the supernatant placed on ice. The supernatant from each sample was 
then diluted in the buffer provided by the manufacturer to a final dilution of 1/320, and 
analyzed in duplicate. Phospholipase C concentration was determined by comparing the 
unknowns, minus the value obtained from a set of duplicate negative controls, against a 
standard curve obtained from known concentrations of a positive control provided by 
the manufacturer. The manufacturer stated lower limit of sensitivity of this assay was 
0.2mU/mL. 
5.3.10. In vitro HEA mediated agglutination 
To evaluate HEA-mediated agglutination, 3.3 X 108 CFUs/mL C. perfringens was 
incubated with anti- C. perfringens and anti-CTX HEA at an endpoint titre of 5.71 for 
15 min at room temperature. The incubated solutions were placed on glass slides and 
agglutination visually evaluated under 400X magnification on a Axiostar plus Zeiss 
microscope (Carl Zeiss Vision GmbH, Germany) fitted with Axiocam MRc camera. 
The solutions were also plated on BAneo+ plates for enumeration of C. perfringens. 
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5.3.11. Statistical analysis 
Individual birds were considered the experimental unit in both experiments. 
Bacterial numbers at each anatomical site were log transformed to normalize them prior 
to analysis. Statistical analyses of bacterial populations, in vivo antibody titres, and 
phospholipase C concentrations were done using a one-way analysis of variance with 
diet or anatomical location as the independent variables (SPSS v.13.0, SPSS Inc, 
Chicago IL, USA). Treatment effects were considered significant when P < 0.05. 
Lesion scores were analyzed using a two-tailed Mann-Whitney U test. Differences 
between medians were considered significant when P < 0.05. 
5.4. Results 
After immunizing laying hens repeatedly, the pooled anti-C. perfringens and anti-
Ctx antibody titres were determined to be 1:256,000 and 1:512,000, respectively. 
Following PEG precipitation the anti-C. perfringens and anti-Ctx titres were both 
determined to be 1:1,024,000. Anti-C. perfringens and anti-Ctx titres in feed were 
1:60,000 and 1:72,000, respectively. This difference was due to the differences in the 
amount of total protein in each concentrated HEA. Balancing the amount of added 
protein resulted in differences in the amount of specific antibodies that were added to 
each diet. Using the anti-CTX amended feed, measurable antibody activity in vivo was 
observed (Figure 5.1). Except for the crop and duodenum, there was a significant (P < 
0.05) decrease in the antibody activity moving proximal to distal within the intestine.  
In experiment 1 there were no significant differences in the number of C. 
perfringens found in either the cecum or ileum of birds receiving the anti- C. 
perfringens HEA compared to the birds receiving the anti-Ctx HEA at hour 0, 24 or 72  
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Figure 5.1. The log10 of the inverse endpoint titres of anti-cholera toxin hen-egg 
antibody in feed and five intestinal locations from experimental chickens after 48 
hours of consuming HEA-amended feed. Bars represent the mean ± SEM (n = 10). 
abcdeBars with different superscripts are significantly different (P < 0.05). 
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 (Figure 5.2). In experiment 2, there was a significantly lower number of C. perfringens 
found in both the ileum and cecum of the birds receiving the anti- C. perfringens HEA 
(P < 0.05) at hour 72, however at all other sampling times, there were no significant 
differences between treatment groups (Figure 5.3). At this same sampling time, 
however, the mean PLC (alpha-toxin) concentration (± SEM) detected in the contents of 
the birds receiving the anti- C. perfringens HEA feed were the same (P = 0.57) as that 
of the control feed: 51 ± 5 and 47 ± 6 mU/g contents, respectively. 
Intestinal-lesion scores were significantly higher in birds receiving the anti-C. 
perfringens HEA diets than in those fed the anti-CTX HEA diets at the hour-24 and -72 
sampling times (Table 5.2). The lesions commonly were observed as hemorrhagic in the 
ileum and caecal tonsil region. 
Molecular enumeration of the hour-72 ileal samples obtained in experiment 2 
revealed more C. perfringens in both the anti-Ctx and anti-C. perfringens HEA groups  
compared to plate counts using traditional plating on BAneo+ (Figure 5.4). This approach 
also showed no significant difference (P < 0.05) in C. perfringens abundance between 
treatment groups. 
The in vitro incubation of C. perfringens with either anti-C. perfringens or anti-CTX 
HEA resulted in visible agglutination of C. perfringens in the presence of anti- C. 
perfringens, but not in the presence of anti-CTX HEA. The observed in vitro 
agglutination also resulted in a significant (P = 0.02 ) reduction in C. perfringens  plate 
counts from 8.50 ± 0.06  log10 CFUs/mL for the samples incubated with anti-CTX 
HEA, to 8.29 ± 0.05 log10 CFUs/mL for those samples incubated with anti-C. 
perfringens HEA.  
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Figure 5.2. Experiment 1 ileal (A) and cecal (B) C. perfringens counts from 
challenged birds at 0, 24, and 72 hours following change to either anti- C. 
perfringens of anti-CTX HEA amended feeds. Bars represent the mean ± SEM (n = 
10). 
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Figure 5.3. Experiment 2 ileal (A) and cecal (B) C. perfringens counts from 
challenged birds at 0, 24, and 72 hours following change to either anti- C. 
perfringens of anti-Ctx HEA amended feeds. Bars represent the mean ± SEM (n = 
15). * indicates significantly lower counts (P < 0.05). 
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Table 5.2. Intestinal-lesion scores 0, 24 and 72 hours after change to antibody 
amended feed in Experiment 2.  
 
Values represent number of birds within a group with the lesion score indicated. The Mann-Whitney U test was used to determine 
differences between dietary treatment groups and the groups were considered significantly different when P < 0.05. 
 
 
0.020.010.09P - value 
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102 61614 
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Figure 5.4. Comparison of C. perfringens counts in cecal contents 72 hours 
following change to antibody-amended feed determined by culture-based colony 
enumeration and real-time quantitative PCR. Bars represent the mean ± SEM (n = 
15). * indicates significantly lower counts (P < 0.05). 
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5.5. Discussion 
Immunization of laying hens with both the CTX and C. perfringens bacterin 
resulted in good antibody titres in the collected eggs, which after concentration and 
incorporation into diets, resulted in endpoint titres in excess of those used by other 
researchers (Yokoyama et al., 1992; Yokoyama et al., 1993). Using the anti-CTX 
amended diet, we demonstrated antibody activity throughout the entire length of the 
intestinal tract of broiler chickens using an ELISA antibody activity assay. We chose to 
use anti-CTX HEA for this because cholera toxin should not be present in the intestinal 
lumen of the bird and there should be no binding of the antibody to antigen that could 
potentially reduce the sensitivity of our ELISA. The observed activity of the 
administered antibody in the intestinal tract agrees with results obtained for other 
animal species including pigs (Yokoyama et al., 1993) and rainbow trout (Lee et al., 
2000) where temporal and spatial HEA activity in the intestine was examined after a 
single bolus dose. In our trial the antibody was administered in feed and thus resulted in 
measurable activity throughout the entire gastrointestinal tract at 48 hours. The constant 
administration of antibody would be most reflective of a commercial setting where 
sustained presence of antibody would be necessary for prophylaxis or therapy of enteric 
infection. Others have attempted to improve HEA efficacy by applying treatments to 
protect immunoglobulins from denaturation and proteolytic degradation in the upper 
intestinal tract (Kovacs-Nolan and Mine, 2005; Sugita-Konishi et al., 2000). We used 
no such protection, however if done, this might have improved their efficacy. 
Although only statistically significant in experiment 2, culture based enumeration 
showed a reduction in intestinal C. perfringens at 72 hours. Subjective observations 
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during sample collection in experiment 1 suggested lesions were more prominent in the 
anti-C. perfringens group-and in experiment 2, lesion scoring confirmed the impression. 
The increase in lesion score however, was not concomitant with an increase in intestinal 
phospholipase C activity (alpha toxin activity). Combined, these observations led us to 
question the validity of the observed reduction in C. perfringens viable counts. 
Enumeration of C. perfringens using qPCR indicated no difference in number of C. 
perfringens genomes enumerated per gram of intestinal contents. We hypothesized that 
the observed reduction in C. perfringens viable plate counts might have been due to 
agglutination of C. perfringens in the intestinal contents by the antibody. Agglutinated 
cells would be enumerated as a single CFU on plate counts but as multiple genomes by 
qPCR.  In this experiment, the bacteria-antibody complexes would need to contain <10 
bacteria since there was less than one order of magnitude difference in the number of C. 
perfringens CFUs between the 2 treatment groups. In support of this hypothesis, the in 
vitro agglutination of C. perfringens cells was readily apparent upon co-incubation with 
anti-C. perfringens antibodies, which resulted in a significant (P = 0.02) reduction in C. 
perfringens as measured using traditional plate counts. Several papers reported the 
effect of specific immunoglobulins on the in vitro growth of bacteria (Rainard, 1986; 
Reiter et al., 1975; Spik et al., 1978; Stephens et al., 1980).  Rainard (Rainard, 1986) 
noted that bovine immunoglobulins induced the appearance of microcolonies in 
suspension due to agglutination of bacteria by the antibody. The author further stated 
that this could cause misleading interpretations of bacterial growth in the absence of 
sonic treatment. Admittedly, the conditions in the intestinal tract are more complex, 
involving antigen concentration and transit time, however because the molecular 
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enumeration of C. perfringens would not be affected by agglutination, this seems a 
plausible explanation for the observed discrepancy. 
The more-severe lesions observed with anti-C. perfringens treatment might be 
related to the agglutination of C. perfringens. Such agglutination at the epithelial 
surface could be accompanied by a similar localized increase in the alpha-toxin 
concentration which could result in an increase in the number of lesions. Additionally, 
this might have involved one of the other toxins produced by C. perfringens, however, 
our in vitro assay examined only alpha-toxin activity. Fulton et al. (2002) found an 
increase in the infection rate among Salmonella-challenged birds fed anti-Salmonella 
HEA, and attributed this increased rate of infection to antibody-mediated opsonization 
of Salmonella. Perhaps opsonization of either organism or toxin might have played a 
role in the increased lesions, however this remains speculative. 
Other researchers have shown no improvement in pathogen colonization or infection 
using HEA raised against bacterins (Fulton et al., 2002) and also Cryptosporidium 
parvum oocysts (Kobayashi et al., 2004). Kobayashi et al. (2004) suggested that using 
specific oocyst surface proteins might serve to increase the efficacy of HEA.  Indeed, 
when antibodies are targeted to specific virulence factors such as attachment fimbria of 
E. coli (Imberechts et al., 1997; Yokoyama et al., 1997), or outer membrane proteins of 
Salmonella spp. (Yokoyama et al., 1998a), infection reduction has been observed. 
These virulence factor-specific antibodies work by blocking or inhibiting attachment 
and thus the subsequent progression of disease (Sugita-Konishi et al., 2000). It is not 
clear however, if the attachment of C. perfringens to the intestinal wall is important to 
the development of necrotic enteritis. What is clear is that alpha-toxin appears to be 
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important to the development of necrotic enteritis (Fukata et al., 1988), so it seems 
plausible that an approach that targets this specific virulence factor might increase the 
potential of passive oral immunotherapy to control gastrointestinal pathogens such as C. 
perfringens.  
Our results indicate that caution should be exercised when interpreting plate-count 
data when oral antibody approaches are used to control intestinal-pathogen 
colonization.  Indeed, in the absence of reduced morbidity or mortality, reduced 
pathogen numbers alone is probably not a sufficient indicator of efficacy because 
agglutination of pathogen might lead to artificially low counts. In addition, although 
HEA have been been efficacious in controlling intestinal infection, we and others have 
observed increased infection when HEA are used, suggesting that this technology needs 
to be closely evaluated for each target pathogen and antibody specificity. 
5.6. Conclusions 
Our results suggest that the oral administration of hen-egg antibodies does not 
reduce intestinal C. perfringens in experimentally challenged birds. The finding of 
increased intestinal lesions in birds administered pathogen-specific antibodies indicate 
that the antibodies might in fact exacerbate necrotic enteritis. Further studies that 
examine antibodies that target specific virulence factors are required. 
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6. DIETARY AMINO ACIDS AFFECT INTESTINAL CLOSTRIDIUM 
PERFRINGENS POPULATIONS IN BROILER CHICKENS 
 
6.1. Abstract 
An experiment was performed to examine the effect of protein source and dietary 
amino acid profile on intestinal levels of C. perfringens in broiler chickens. Broiler 
chickens (age = 14 d; n=192) were fed diets containing 400 g/kg crude protein with fish 
meal, meat/bone meal, feather meal, corn gluten meal, soy protein concentrate, pea 
protein concentrate, or potato protein concentrate as the primary protein source along 
with a control diet containing 230 g/kg crude protein. The birds were orally inoculated 
daily, with 1 mL (~1.0 x 108 CFU/mL) of an overnight culture of C. perfringens 
between 14-21 days of age, killed at 28 days of age and C. perfringens numbers in 
ileum and cecum enumerated. Birds fed fish meal, meat/bone meal, feather meal and 
potato protein concentrate had significantly higher intestinal C. perfringens counts than 
the birds fed corn gluten meal, soy or pea protein concentrates or the control diet (P < 
0.05). The glycine content of the diets and ileal contents was significantly, positively 
correlated with C. perfringens numbers in ileum and cecum. Dietary glycine may be an 
important factor in the intestinal overgrowth of C. perfringens in broiler chickens. 
6.2. Introduction 
Necrotic enteritis is a disease of broiler chickens caused by the overgrowth of  
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Clostridium perfringens types A and C in the small intestine (Dykstra and Reid, 1977; 
Fukata et al., 1991). Outbreaks of necrotic enteritis are sporadic and may result in high 
mortality and severe economic losses (van der Sluis, 2000a; 2000b). Presently, control 
of this disease is achieved using antibiotics and coccidiostats (Feed Additive 
Compendium, 2000), however, the banning of the non-therapeutic use of antibiotics in 
Europe, as well as consumer concerns about their use in other jurisdictions, has led to a 
need for a more comprehensive understanding of the factors which contribute to the 
development of this disease. 
C. perfringens is ubiquitously distributed in the environment, and is almost always 
found in the intestine of healthy birds (Tschirdewahn et al., 1991). However, under 
certain conditions, C. perfringens proliferates rapidly resulting in the development of 
clinical necrotic enteritis. In spite of our present understanding of this disease, and the 
identification of C. perfringens as the etiological agent of necrotic enteritis, the 
predisposing factors that lead to the overgrowth of C. perfringens and the subsequent 
progression to disease are unclear. Necrotic enteritis appears to be a multi-factorial 
disease process in which a number of factors contribute to the development of clinical 
symptoms. Previous research has identified some of the predisposing factors including; 
management practices (Cowen et al., 1987; Hamdy et al., 1983; 1983b; Kalhusdal, et 
al., 1999), environmental conditions (Long, 1973; Kalhusdal and Skjerve, 1996), stress 
(Dykstra and Reid, 1977; Fukata et al., 1991), co-infection with Eimeria spp. (Al-
Sheikhly and Al-Saieg, 1980), the number of C. perfringens present in the gut 
(Kalhusdal, et al., 1999; Williams et al., 2003) and diet. 
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Several dietary factors that have been shown to contribute to the incidence of 
necrotic enteritis including intestinal viscosity (Kalhusdal and Skjerve, 1996), feed 
processing (Branton et al., 1987), or diets based on wheat (Riddell and Kong, 1992) or 
barley (Kalhusdal and Hofshagen, 1992). In addition, it has been shown that diets with 
high levels of protein may also predispose birds to intestinal overgrowth by C. 
perfringens (Kalhusdal, 2000). The relationship between diet, C. perfringens, and 
necrotic enteritis is not fully understood, however, the development of nutritional 
strategies that reduce the intestinal numbers of C. perfringens may also reduce the 
incidence of necrotic enteritis. 
Preliminary work in our laboratory examined the effect of protein source and levels 
on intestinal populations of C. perfringens (Drew et al., 2004). Broiler chickens were 
fed 230 or 400 g/kg crude protein using fish meal (FM) or soy protein concentrate 
(SPC) as the primary protein sources. Birds fed the FM-based diets had significantly 
higher numbers of C. perfringens in ileal and cecal digesta compared to those fed SPC-
based diets at both levels of dietary crude protein. Amino acid analysis of the diets 
indicated that the levels of several amino acids were elevated in the FM diets compared 
to the SPC diets, particularly methionine and glycine. The current studies were 
performed to assess C. perfringens colonization for a wide range of protein sources and 
determine whether increased C. perfringens colonization could be correlated with the 
supply of specific amino acids.  
6.3. Materials and Methods 
6.3.1. Bacterial cultures 
In all experiments a C. perfringens Type A clinical isolate from broiler chickens was  
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used (Dr. M. Chirino, Western College of Veterinary Medicine, University of 
Saskatchewan, Saskatoon, SK). All C. perfringens cultures used for oral gavage of 
broiler chickens were grown anaerobically in Brain Heart Infusion (BHI) for 6 hours at 
37°C (Becton, Dickinson and Co., Sparks, MD, USA) and administered when in 
exponential growth phase (~1.0 x 108 colony forming units/mL (CFU/mL)). 
6.3.2. Animal management 
Experimental protocols were approved by the Animal Care Committee of the 
University of Saskatchewan and were performed in accordance with the 
recommendations of the Canadian Council on Animal Care as specified in the Guide to 
the Care and Use of Experimental Animals (Canadian Council on Animal Care, 1993). 
A total of 192 (Ross 308) (Lilydale Hatchery, Wynyard, SK, Canada) were used in this 
experiment. To improve the intestinal colonization by C. perfringens, newly hatched 
chicks were orally gavaged in the crop with 0.5 mLs of an actively growing culture of 
C. perfringens (~1.0 x 108 CFU/mL) in BHI broth prepared as above using a 12.0 mL 
syringe equipped with vinyl tubing (I.D.0.97 mm, O.D. 1.27mm), and randomly placed 
into one of two battery cages. On days 1 through 14 of the experiment, birds received an 
unmedicated, starter diet containing 315 g/kg crude protein which met the NRC 
requirements for broiler chickens (NRC, 1994) (Table 6.1). On day 14, birds were wing 
banded, weighed, and each bird was randomly assigned to one of 16 battery cages (12 
birds per cage). Two cages of birds were then randomly assigned to one of the 8 
experimental diets shown in Table 6.2. A diet containing 230 g/kg crude protein and 
meeting NRC requirements for broiler chickens (NRC, 1994) was used as a control. The  
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Table 6.1. Starter diet used for all birds from days 0-141. 
 
 
1Diet was formulated to contain 315 g/kg crude protein and meet NRC requirements for broiler chickens. 
2Supplied per kilogram of diet: vitamin A, 3.3 mg; cholecalciferol, 55 μg; vitamin E, 30 mg; vitamin K, 
0.5 mg; vitamin B12; 0.02 mg; thiamine, 1.5 mg; riboflavin, 6 mg; folic acid, 0.6 mg; biotin, 0.15 mg; 
niacin, 60 mg; pyridoxine, 5 mg; 400 mg; chloride, 788 mg; sodium, 511 mg; iron, 80 mg;  manganese, 
21.8 mg; selenium, 0.1 mg; iodine, 0.35 mg; zinc, 100 mg. 
5.0Vitamin/Mineral premix 2
1.0Choline chloride
17.0Canola oil
16.0Limestone 
220.0Wheat 
411.6Corn 
329.4Fish meal 
g kgIngredient /
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Table 6.2. Experimental diet formulations fed to birds on days 14-28 of the 
experiment. 
 
 
1Same composition as Table 6.1. FM = fish meal; MBM = meat and bone meal; FeM = feather meal; 
PoPC = potato protein concentrate; PePC = pea protein concentrate; SPC = soy protein concentrate; CGM 
= corn gluten meal 
1000.01000.01000.01000.01000.01000.01000.01000.0
5.05.05.05.05.05.05.05.0 Vit Min premix 1 
1.01.01.01.01.01.01.01.0 Choline Cl 
6.711.810.112.912.317.026.212.1Ca carbonate
20.020.020.020.067.8121.574.220.0Canola oil
200.0200.0200.0 200.0200.0200.0200.0200.0 Wheat 
196.3223.6346.6 325.0291.79.2124.0512.3 Corn
571.1-- ----- CGM 
-538.6- ----79.6SPC 
--436.1 ----- PePC 
--- 417.2---- PoPC
--- -422.1--- FeM 
--- --646.2-- MBM
--- ---569.6169.9 FM
CGMSPCPePC PoPCFeMMBMFMControlIngredient
g/kg
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other 7 diets were formulated to contain 400 g/kg  crude protein using fish meal (FM), 
meat and bone meal (MBM), feather meal (FeM), potato protein concentrate (PoPC), 
pea protein concentrate (PePC), soy protein concentrate (SPC) or corn gluten meal 
(CGM) as the primary source of protein. All diets were isoenergetic (13.4 MJkg), did 
not contain antibiotics or coccidiostats and were not pelleted. Amino acid analysis of 
the different feeds was performed by Degussa Corporation (Allendale NJ, USA).  
Birds were orally gavaged daily, from days 14 to 21 with 1.0 mL of a 6 hour broth 
culture of C. perfringens (~1.0 x 108 CFU/mL) in BHI, using the same method for the 
delivery of inoculum as above. Throughout the experimental period chicks had free 
access to feed and water. At 28 days of age, birds were euthanised by cervical 
dislocation and their intestinal tracts were removed. The contents of the ileum from 
Meckel’s diverticulum to the ileal cecal junction and the contents of both ceca were 
aseptically collected from each bird with the contents from 2 birds being pooled. A 
subsample of the pooled ileal and cecal contents was diluted in sterile peptone 
containing 0.5% cysteine hydrochloride and immediately placed on ice. These 
subsamples were serially diluted in sterile peptone containing 0.5% cysteine 
hydrochloride and plated in duplicate using an automated spiral plater (Autoplate, Spiral 
Biotech Inc., Bethesda, MD, USA) on BBL™ Blood Agar Base (Becton, Dickinson and 
Co., Sparks, MD, USA) containing 5.0% sheep blood and 0.01% Neomycin Sulfate 
(BAneo+) (The Upjohn Company, Orangeville, ON, Canada) for the enumeration of C. 
perfringens, and MRS agar (Becton, Dickinson and Co., Sparks, MD, USA) for the 
enumeration of lactobacilli and other lactic acid bacteria (LAB). The BAneo+ plates were 
incubated anaerobically for 24 hours at 37°C. MRS plates were incubated anaerobically 
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for 48 hours at 37°C. Colonies exhibiting a double zone of hemolysis on the BAneo+ 
were counted as C. perfringens with presumptive colonies being randomly picked, gram 
stained, plated on Mannitol Yolk Polymixin agar (Oxoid Inc., Napean, ON, Canada) 
and examined microscopically to confirm them as C. perfringens. The remainder of the 
pooled ileal contents were lyophilized and analyzed for amino acid content (Degussa 
Corporation, Allendale NJ, USA). 
6.3.3. In vitro effect of various amino acids on the growth of C. perfringens 
The growth of C. perfringens was assessed in an in vitro system using a mixed 
bacterial culture derived from C. perfringens-positive (~1.02 x 105CFUs/g) pooled 
intestinal contents from birds fed the 400 g/kg crude protein FM-based diet. In the first 
in vitro experiment, one gram of intestinal contents was resuspended in 9.0 mL of 
sterile minimal salts media, vigorously vortexed for 5 min and allowed to settle for 45 
min. The minimal salts media consisted of equal volumes of Solution A and Solution B. 
Solution A consisted of (per liter) 2.0 g NaCl, 1.0 g NH4Cl, 0.12 g MgSO4.7H2O and 
1.0 mL of a trace element solution containing (per liter) 4.0 g EDTA, 1.5 g CaCl2, 1.0 g 
FeSO4.7H2O, 0.35 g MnSO4.2H2O and 0.5 g NaMoO4.2H2O. Solution B consisted of 
(per liter) 4.24 g Na2HPO4 and 2.7 g KH2PO4. Solution A and B were autoclaved 
separately, cooled, and mixed aseptically. One mL of resuspended contents was then 
added to duplicate sterile 15 mL conical tubes containing 9.0 mL of a 10 mg/mL 
solution of alanine, glycine, leucine, or methionine in sterile minimal salts media. A 
negative control was included which contained minimal salts media alone. At time 0, 8 
and 24 hours post inoculation a 50.0µL sample was removed from each conical tube 
and plated on BAneo+ plates as described above. All media was pre-reduced and the 
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experimental incubations were performed in an anaerobic glovebox (Forma Scientific, 
Marietta, OH, USA) at 37˚C. To facilitate the utilization of the added amino acids by 
the intestinal inoculum, and to ensure the tubes were well mixed when sampled, 
inoculated conical tubes were gently rocked while incubating. 
In the second in vitro experiment, two grams of intestinal contents was resuspended 
in 200 mL of sterile minimal salts media, vigorously vortexed for 5 min and allowed to 
settle for 45 min. Ten mL of the suspension was then added to quadruplicate sterile 15 
mL conical tubes containing 100 mg of either glycine, lysine, leucine, or methionine, 
for a final amino acid concentration of 10 mg/mL. A negative control was included 
which contained minimal salts media alone. At time 0, 8 and 24 hours post inoculation, 
a 50.0µL sample was removed from each conical tube and plated on BAneo+ and MRS 
agar plates as described above. 
6.3.4. Statistical analysis 
Bacterial counts and growth performance were analyzed using the general linear 
model of SPSS (v.10.0.5, SPSS Inc, Chicago IL, USA). Diet or amino acid treatment 
means were compared using the Ryan-Einot-Gabriel-Welsch multiple F test, and were 
considered significantly different when P < 0.05. Bivariate correlation analysis was 
performed between C. perfringens populations in ileum and cecum and levels of amino 
acids in the 8 diets and intestinal contents of the birds feed each diet. Pearson’s 
correlation coefficient (r) was considered significant when P < 0.05. 
6.4. Results 
Subsequent to challenge with C. perfringens no clinical signs of necrotic enteritis 
were observed in any of the treatment groups or the control group. During the course of 
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this trial 2 birds died (one each from one of the PePC and SPC dietary groups) of causes 
unrelated to C. perfringens challenge. The ileal and cecal C. perfringens and LAB 
counts on day 28 of the experiment are shown in Figure 6.1. With the exception of 
chickens fed potato protein concentrate, the number of C. perfringens in the cecal 
contents of chickens fed diets that contained protein from animal sources was 
significantly higher than those chickens fed diets containing protein from plant sources 
(P < 0.05). Likewise, the ileal C. perfringens counts were found to be significantly 
higher in the birds fed animal protein-based diets compared to those fed the control diet 
or the plant protein-based diets, with the exception of the birds fed the PoPC diet which 
had ileal C. perfringens numbers that were not significantly different from either the 
animal protein-based diets, or the plant protein-based diets (P > 0.05). Cecal plate 
counts obtained for LAB revealed no significant differences among treatment groups, 
however a significantly lower number of LAB was observed in the ileum of birds fed 
the MBM diet compared to the group fed CGM. 
The amino acid analysis of the diets and ileal contents is shown in Tables 6.3 and 
6.4, respectively. Correlation analysis revealed a significant correlation (P < 0.05) 
between the level of glycine found in the diet and the number of C. perfringens in both 
ileum and cecum (Table 6.5). Correlations between all other dietary amino acids and C. 
perfringens populations were not significant (P > 0.05). Significant correlations 
between the lysine and glycine content of ileal digesta and C. perfringens numbers in 
both ileum and cecum were observed. No other ileal amino acids were significantly 
correlated with C. perfringens populations in ileum or cecum. 
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Figure 6.1. C. perfringens and LAB populations in ileum (A) and cecum (B) of 
broiler chickens fed diets based on different protein sources.. abcdBars within 
intestinal location and bacterial species with different superscripts are significantly 
different (P < 0.05), and represent the mean ± SEM (n = 12). FM = fish meal; 
MBM = meat and bone meal; FeM = feather meal; PoPC = potato protein 
concentrate; PePC = pea protein concentrate; SPC = soy protein concentrate; 
CGM = corn gluten meal 
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Table 6.3. Protein and amino acid composition of the diets (as is basis). 
 
 
FM = fish meal; MBM = meat and bone meal; FeM = feather meal; PoPC = potato protein concentrate; 
PePC = pea protein concentrate; SPC = soy protein concentrate; CGM = corn gluten meal 
91.072.976.7 49.156.154.556.539.2Glu 
24.140.447.8 42.829.729.334.019.8Asp 
35.417.319.4 20.221.927.427.213.3Ala
38.322.321.5 21.041.431.824.313.9Pro 
21.118.521.2 19.644.316.518.09.7Ser
11.516.017.7 18.633.447.936.711.4Gly 
24.318.523.1 22.520.813.214.610.1Phe 
8.710.711.0 9.46.48.59.97.2His 
18.718.422.0 24.029.716.517.411.2Val
64.730.236.9 38.136.724.527.719.2Leu 
15.917.220.3 20.119.711.214.29.5Ile
12.826.634.3 19.529.226.526.213.3Arg 
2.24.83.3 4.62.9nd3.62.6Trp
13.414.415.1 19.719.413.116.08.6Thr
6.521.629.3 25.910.919.725.213.1Lys 
7.05.64.8 5.316.44.13.83.1Cys 
8.75.24.2 7.93.45.510.14.7Met
363.1402.3469.6 341.8 409.1413.3400.9231.5Protein (N x 6.25)
CGMSPCPePC PoPC FeMMBMFMControl
g/kg
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Table 6.4. Amino acid content of ileal contents (dry matter basis). 
 
 
FM = fish meal; MBM = meat and bone meal; FeM = feather meal; PoPC = potato protein concentrate; 
PePC = pea protein concentrate; SPC = soy protein concentrate; CGM = corn gluten meal 
37.321.725.7 28.359.230.628.419.4Glu 
16.826.425.2 29.252.829.934.422.2Asp 
14.67.612.3 12.322.016.113.29.1Ala
17.97.411.3 11.647.020.212.09.2Pro 
11.47.611.9 14.546.111.911.78.3Ser
11.09.012.5 14.235.532.621.210.6Gly 
10.46.111.6 12.117.87.99.36.9Phe 
5.73.95.5 6.07.35.46.04.6His 
11.37.614.3 14.928.410.410.98.4Val
23.010.218.4 19.434.314.214.311.3Leu 
8.96.311.7 12.617.17.29.06.7Ile
6.95.911.9 9.524.314.111.36.5Arg 
2.42.13.4 4.94.22.43.42.3Trp
10.79.311.8 16.425.310.211.59.2Thr
5.66.812.2 13.614.112.212.98.4Lys 
6.53.96.2 7.526.45.04.13.5Cys 
3.41.83.6 4.23.53.14.92.8Met
226.7172.7245.1 246.0 488.8300.0255.5175.3Protein (N x 6.25)
CGMSPCPePC PoPC FeMMBMFMControl
g/kg
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Table 6.5. Pearson correlation (r) coefficients between the amino acid content of 
diets and ileal digesta and intestinal populations of C. perfringens. 
 
0.2660.227-0.589-0.588Glu
0.6480.6310.1570.044Asp
0.4290.4490.0410.083Ala
0.3190.3050.1360.105Pro
0.3460.3020.2360.168Ser
0.714*0.759*0.807*0.893*Gly
0.2630.206-0.250-0.422Phe
0.4810.482-0.132-0.146His
0.3270.2720.3160.154Val
0.1270.066-0.426-0.525Leu
0.3060.2280.019-0.162Ile
0.5330.5650.3390.408Arg
0.5360.396-0.095-0.252Trp
0.4250.3120.5550.360Thr
0.801*0.809*0.3470.343Lys
0.2670.2030.1440.058Cys
0.4660.5610.1520.152Met
0.5010.4960.1810.222Crude Protein
CecumIleumCecumIleum
Ileal Amino AcidsDietary Amino Acids
 
*Correlation coefficients are significant (P < 0.05) 
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The results from the first in vitro experiment are shown in Figure 6.2. Although no 
significant differences were observed at 0 or 8 hours, at 24 hours the number of C. 
perfringens was significantly increased in medium containing glycine compared to the 
control medium (5.33 ± 0.01 and 5.10 ± 0.03 log10 CFU/mL, respectively). In contrast, 
media containing methionine, leucine or alanine supported significantly lower numbers 
of C. perfringens compared to the control (4.87 ± 0.03, 4.98 ± 0.04, and 5.01 ± 0.04 
log10 CFU/mL, respectively). 
In the second in vitro experiment (Figure 6.3), similar results were observed with no 
significant differences observed at hours 0 or 8. At 24 hours, however, significantly 
higher numbers of C. perfringens were observed in both the glycine and lysine amended 
cultures (5.86 ± 0.03 and 5.66 ± 0.07 log10 CFU/mL, respectively), compared to the 
methionine, leucine, or the negative control (4.88 ± 0.07, 4.90 ± 0.05 and 4.77 ± 0.04 
log10 CFU/mL, respectively). In addition, significant differences were observed in the 
ability of the various amino acids to support the population of LAB from the same 
intestinal contents. After 24 hours incubation, the glycine-containing media supported 
significantly fewer LAB than the lysine or methionine containing media (7.26 ± 0.02, 
7.82 ± 0.03 and 7.70 ± 0.06 log10 CFU/mL, respectively). 
6.5. Discussion 
Although necrotic enteritis is an economically important disease of broiler chickens, 
the development of a reproducible experimental model for this disease has proven 
difficult. C. perfringens is recognized as the etiological agent of necrotic enteritis but 
other contributing factors are usually required to initiate clinical disease. These 
predisposing factors include management stress, sub-clinical intestinal coccidiosis,  
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Figure 6.2. In vitro growth of C. perfringens after 24 hours incubation of intestinal 
contents in minimal salts media supplemented with different amino acids1.  
 
Footnotes to Figure 2. 
abcBars with different superscripts are significantly different (P < 0.05), and represent the mean ± SEM (n 
= 4). Final concentration of amino acids was 10 mg/mL 
1Mean C. perfringens count at time 0 hours was 5.09 Log10 CFU per mL of culture (SEM = 0.05). 
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Figure 6.3. In vitro growth of C. perfringens and LAB after 24 hours incubation of 
intestinal contents in minimal salts media supplemented with different amino 
acids1. 
 
 
 
 
Footnotes to Figure 3.  
abcBars with different superscripts are significantly different (P < 0.05), and represent the mean ± SEM (n 
= 4). Final concentration of amino acids was 10 mg/mL 
1Mean of C. perfringens and LAB numbers per mL of culture material at time 0 hours was 4.93 
Log10 CFU/mL (SEM = 0.07) and 5.48 Log10 CFU/mL (SEM = 0.02), respectively.
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changes in dietary formulation and alteration of feeding programs (Kalhusdal, 2000; 
Shane et al., 1985). These factors are numerous, but many are ill-defined and 
experimental results have been contradictory (Kalhusdal et al., 1999). This lack of a 
reliable experimental model for necrotic enteritis has hampered efforts to evaluate 
putative risk factors and preventive measures. The model used in the current study is 
based on populations of C. perfringens in the ileum and cecum and no overt clinical 
signs of necrotic enteritis were noted during the experiment. The numbers of C. 
perfringens in the normal chicken gut vary considerably from sporadic and low 
numbers to 107 CFU/g or more (Ficken and Wages, 1997; Engberg et al., 2002). 
However, since C. perfringens is the etiological agent of necrotic enteritis it seems 
reasonable to assume that increased numbers of this organism in the gut are associated 
with an increased predisposition to clinical necrotic enteritis.  
Dietary composition has been shown to have important effects on the incidence of 
necrotic enteritis in broiler chickens. Long and Truscott (1976) used a pure culture 
challenge model to reproduce necrotic enteritis in broiler chickens with total necrotic 
enteritis mortality ranging from 1-28%. This model was later modified to feed birds 
elevated dietary concentration of fish meal prior to initiation of inoculum administration 
and intra-duodenal administration of inoculum (Truscott and Al-Sheikhly, 1977). 
Elevated concentration of dietary wheat and barley (Riddell and Kong, 1992), animal 
proteins (Kalhusdal and Skjerve, 1996) and zinc (Baba et al., 1992) may also exacerbate 
necrotic enteritis. More recently, Williams et al. (2003) reported that a combination of 
diet (high inclusion of wheat and fish meal), infection with Eimeria maxima followed 
by per cloaca inoculation with C. perfringens 6 days later resulted in intestinal lesions 
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but no mortality. Clearly, diet has a significant impact on C. perfringens populations in 
the intestinal tract but the causative factors associated with various diets have not been 
identified. 
Kaldhusdal and Skjerve (1996) performed a longitudinal study of necrotic enteritis 
and broiler chicken feeding practices in Norway over a 20 year period. They reported 
that the increased use of rendered animal products was associated with an increase in 
the incidence of necrotic enteritis. Several experimental studies have reported that the 
source and level of protein in diets significantly affects the number of C. perfringens in 
intestinal contents in chickens (Drew et al., 2004), pigs (Mansson and Smith, 1962; 
Mansson and Olhagen, 1967) and dogs (Zentek, 2000; Zentek et al., 1998; 2003). 
Studies were performed in the 1960s in pigs on the effect of dietary protein level on the 
numbers of C. perfringens shed in feces. Mansson and Smith (1962) placed 8-week-old 
pigs on a diet high in crude protein and reported that there was an increase in the 
number of C. perfringens type A from about 2.5x102 per gram in feces from pigs on a 
normal diet to 106 per gram in the feces of pigs on the high protein diet. In another 
study, Mansson and Olhagen (1967) demonstrated that when pigs were fed on a high 
protein diet the number of C. perfringens type A was significantly increased in the feces 
5 to 10 days after being put on the diet. 
Zentek (2000) compared the effect of feeding a low protein diet (22% crude protein) 
to a high protein diet (63% crude protein) containing 51% greaves meal (beef/pork by-
product) to dogs. Intestinal populations of both Streptococcus spp. and LAB were 
unaffected by diet, but intestinal numbers of C. perfringens increased from 106 to 109 
CFU/g. In another study, Zentek et al. (1998) compared the effect of feeding high 
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protein diets composed of either protein from animal (greaves meal) or plant (soy 
protein hydrolysate or corn gluten meal) sources. Dogs fed greaves meal diets had 
increased levels of C. perfringens in their ileal chime, compared to animals fed the 
plant-based protein diets. 
A previous study in broiler chickens examined the effects of protein source (animal 
vs. plant protein) and protein concentration on intestinal populations of C. perfringens 
in broiler chickens (Drew et al., 2004). Fish meal and soy protein concentrate were the 
animal and plant protein sources used at crude protein levels ranging from 230 to 400 
g/kg. At 28 days of age, C. perfringens counts in ileum and cecum increased 
significantly (P < 0.05) as crude protein level increased from 230 to 400 g/kg in birds 
fed fish meal-based diets but not in birds fed SPC-based diets. Thus, crude protein level 
alone does not adequately explain the changes in C. perfringens populations. 
In the present study, C. perfringens numbers were elevated in chickens fed animal 
protein-based diets (FM, MBM and FeM) compared to those fed plant protein-based 
diets (PePC, SPC, CGM). However, PoPC did not fit this pattern and numbers of C. 
perfringens were similar to those seen in the birds fed animal protein-based diets. 
Correlation analysis of the amino acid composition of the diets and C. perfringens 
populations showed that only glycine was significantly correlated with C. perfringens 
numbers. The glycine content of the animal protein-based diets was approximately 2 to 
4 times that found in plant protein-based diets. Potato protein concentrate had the 
highest glycine content of the plant-based ingredients (18.6 g/kg) and this may have 
accounted for the high C. perfringens seen in birds fed the diet based on this protein. In 
ileal contents, glycine and lysine content was significantly correlated with C. 
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perfringens numbers. While interesting that a correlation for glycine and lysine was 
observed in the ileal contents, the amino acid content of the ileal contents reflects 
unavailable dietary protein, endogenous protein losses, and the net effect of bacterial 
nitrogen metabolism. Thus, ileal glycine content is not necessarily a reflection of dietary 
glycine content complicating the interpretation of this correlation. 
Although populations of C. perfringens were affected significantly by diet, with the 
exception of a significant increase in LAB populations in the CGM-fed birds compared 
to the group fed MBM, there was no effect of diet on LAB numbers in ileum or cecum. 
Zentek et al., (1998) also reported that the number of LAB and Streptococcus spp. in 
the intestinal contents of dogs were unaffected by the level or source of protein. 
However, a later study (Zentek et al., 2003) reported that the number of bifidobacteria 
were reduced to undetectable levels in the feces of dogs fed diets containing 726 g/kg of 
crude protein while populations of C. perfringens were significantly increased. Thus it 
is unclear whether the diets employed in the current study influenced C. perfringens 
colonization in the intestine directly or indirectly by modifying colonization of 
commensal bacteria other than LAB. 
Results of the C. perfringens challenge study suggested dietary constituents 
common among animal source proteins and potato meal support increased C. 
perfringens colonization of the intestine, or alternatively, plant based protein sources 
contain constituents which inhibit C. perfringens colonization. Since glycine content 
was markedly higher in the diets supporting C. perfringens colonization and glycine 
content positively correlated with C. perfringens counts, we tested the effect of various 
amino acids on C. perfringens growth in vitro. 
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Although an in vitro approach using a C. perfringens pure culture would yield 
results demonstrating the ability of C. perfringens to use various amino acids, it fails to 
take into account competition for the amino acids from other community members or 
co-metabolic processes which both may influence the actual proliferation of C. 
perfringens in vivo. Thus, a mixed culture was used which was obtained from intestinal 
contents of birds which had received the FM diet in the feeding experiment.  
For both in vitro trials glycine was shown to support significantly higher growth of 
C. perfringens in mixed culture after 24 h. In the second trial lysine was shown to also 
be capable of supporting C. perfringens in mixed culture supporting the observation that 
the lysine content of ileal digesta was significantly correlated with C. perfringens 
populations in ileal and cecal contents. In contrast, glycine supported significantly less 
growth of LAB compared to lysine. These results were contradictory to the results we 
obtained in vivo where no significant effect of glycine on LAB colonization was 
observed. In the absence of additional nutrients, the reduction in the available nutrient 
pool may have resulted in exaggerated differences in various community members. 
The present studies support the hypothesis that the dietary glycine may play an 
important role in supporting the overgrowth of C. perfringens, in the ileum and cecum 
of broiler chickens thereby increasing the potential for an outbreak of clinical necrotic 
enteritis. This is further supported by the observation that glycine is stimulatory for the 
both growth of C. perfringens and alpha toxin production (Ispolatovskaya, 1971; 
Nakamura et al., 1978). Improved knowledge of the effect of specific dietary 
components on intestinal C. perfringens populations may aid in the formulation of 
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broiler diets that reduce the incidence of necrotic enteritis especially in the absence of 
growth promoting antibiotics. 
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7. OVERALL CONCLUSIONS 
In addition to anecdotal evidence, there is a considerable body of evidence in the 
literature which would suggest that the administration of probiotics, and in particular 
organisms such as Bifidobacterium and Lactobacillus spp., does improve animal health. 
Proposed mechanisms include competition for both intestinal binding sites, and a 
limited nutrient supply. It seemed logical therefore to expect that constant 
administration of a probiotic organism of chicken origin would result in a reduction in 
the number of allochthonous microorganisms, including human pathogens such as S. 
enteritidis and C. jejuni. In terms of these two model pathogens however, we did not 
observe any significant differences between our treatment groups and negative controls. 
This despite the fact that both probiotic organisms used were of chicken origin and their 
ability in vitro to survive the harsh conditions encountered in the proximal intestine. 
Moreover, in the case of L. fermentum, our isolate performed better than commercial 
Lactobacillus cultures sold as probiotics. The results suggest that in addition to being 
able to withstand the first line of intestinal defence such as the bile and low pH 
encountered in the crop, stomach, and proximal small intestine, other factors clearly 
contribute to a probiotic microorganism’s ability to out compete allochthonous 
microorganisms, and pathogenic microorganisms in particular. These factors may 
include the prerequisite production of antimicrobial compounds by potential probiotic 
strains, or more poorly defined factors such as the ability to specifically modulate the 
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chicken immune system. Thus, there is a need to further investigate, and ultimately 
identify, all the factors that contribute to the success or failure of a probiotic 
microorganism if they are to receive widespread use and acceptance. 
Passive oral immunization of other animal species with hen-egg antibodies has 
proven to be very efficacious in reducing the morbidity and mortality caused by enteric 
diseases of bacterial origin. In our studies however, using our challenge model we were 
unable to demonstrate their ability to reduce the level of intestinal colonization of our 
model pathogens. These negative results were observed despite their demonstrated 
survival and activity in the entire gastrointestinal tract, as well as their in vitro ability to 
reduce intestinal or mucus attachment by S. enteritidis or C. jejuni, respectively. This 
may have been due, in part, to the fact that S. enteritidis and C. jejuni are not poultry 
pathogens. Because poultry merely serve as a reservoir for these human pathogens, 
these two microorganisms would lack the appropriate virulence factors, such as 
attachment pili, which would stimulate and subsequently be used by the host to clear the 
infection. Even if our antibodies were specifically targeted to the virulence factors 
which make them pathogenic to humans, it is uncertain whether they would make a 
difference in the chicken model. With the poultry pathogen C. perfringens, attachment 
does not appear to be a prerequisite for infection and thus there was no significant 
reduction in the level of intestinal colonization when hen-egg antibodies were 
administered. Surprisingly, however, there was an increase in the frequency and 
severity of intestinal lesions. Although the reasons for this are unclear, the lesions 
seemed most severe in the cecal tonsil region and as such it may be due to opsonization 
of α–toxin, the microorganism itself, or both. Although this approach may hold 
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promise, in terms of our three model pathogens, there is a disconnect between 
functionality and efficacy, and more research is required to identify the specific 
virulence factors required by pathogens to cause disease and if these are appropriate for 
the animal model in question. 
Identifying pathogen-specific virulence factors may ultimately increase the efficacy 
of intervention strategies such as hen-egg antibodies, however the identification of 
predisposing factors, which can actually increase the risk of disease in the first place, 
may be of equal or more importance. Identification of predisposing factors might allow 
us to better manage the microbial ecology of the gut and is illustrated by our study 
examining the relationship between dietary protein and necrotic enteritis. Using diets 
that varied in the protein source used for formulation, it was shown that dietary protein, 
and amino acid profile in particular, may play a role in predisposing broiler chickens to 
necrotic enteritidis by specifically altering intestinal bacterial populations. Thus, it 
seems logical that dietary manipulation may have a role that is equally important in 
disease prevention than any intervention strategy. Complicating the relationship that 
diet may have on managing the microbial ecology of the gastrointestinal tract is the 
observation that a large number of dietary components appear to influence the intestinal 
microflora. Clearly, more research is needed if we are to identify which dietary factors 
are involved in each particular disease, and if the nature of the observed effect is 
indirect or direct. 
In the current studies, a direct challenge model was used for the all three pathogens. 
In all three challenge models birds were orally gavaged with a consistent titre of 
pathogen. To what extend this model reflects the encounter of pathogen in a commercial 
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setting is questionable. For both S. enteritidis and C. jejuni, a review of the literature 
indicated that a challenge dose of 1 x 105 CFU/mL or less resulted in inconsistently 
colonized birds. In all likelihood even this challenge dose is artificially high relative to 
the challenge dose experienced in commercial poultry flocks. However, in an attempt to 
ensure a consistent and uniform level of colonization from an experimental point of 
view, we chose to orally gavage birds with 1 x 108 CFU/mL. In this respect, our 
challenge model was effective, however in the end the two intervention strategies were 
unsuccessful. It is possible that the high challenge dose overwhelmed the intervention 
strategies investigated and that under lower challenge doses, more representative of a 
commercial setting, a better outcome may have been observed. Employing a “Trojan” 
or seeder-model may have been a more realistic approach to mimic pathogen challenge 
in a commercial setting. Not only would this approach better model the natural spread 
of pathogens within poultry flocks, but it might be a better model for pathogen control 
using biological measures such as hen-egg antibodies or probiotics. 
In addition to the high pathogen titres used to infect birds, timing of the pathogen 
challenge may have had a negative effect on the experimental outcome of all trials. The 
ability of the probiotics or egg-antibodies to reduce or exclude pathogens may have 
been increased had they been administered prior to the administration of the pathogens. 
With probiotics in particular, niche occupation by L. fermentum or B. animalis may 
have excluded, or reduced, the ability of the pathogens to become established in the 
gastrointestinal tract. In particular, this may have been beneficial with S. enteritidis 
where epithelial attachment and translocation may be more important in the persistence 
of S. enteritidis in poultry flocks, however a mucus layer covered by antibody or 
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probiotic may also inhibit intestinal colonization by C. jejuni. In retrospect this seems 
logical, as niche occupation by C. perfringens was the rationale for gavaging the birds 
on day-of-hatch and was very effective in ensuring intestinal colonization. If the timing 
of the pathogen challenge was changed to post probiotic or egg-antibody administration, 
perhaps revisiting the model would have been appropriate as well.  
The challenge model used for C. perfringens was different and in part reflected the 
unique nature of an opportunistic pathogen. Not only were birds orally gavaged with a 
high challenge dose on day-of-hatch, but they were orally gavaged for an additional 
seven days from day 14 through 21. This challenge model was based on work done by 
both others and ourselves and resulted in a very reliable model for intestinal 
colonization. This challenge model however, did not produce clinical necrotic enteritis. 
Nearly without exception, all current necrotic enteritis models employ a polymicrobial 
challenge using Eimeria spp., yet the etiological agent is the common intestinal 
inhabitant C. perfringens. We chose to examine intervention strategies and dietary 
factors that contribute to intestinal colonization by C. perfringens in the absence of 
disease, rather than attempting to address the more complex factors that control a 
polymicrobial infection. 
Despite the intestinal colonization levels that we were able to achieve using our 
challenge models, some birds appeared to be pathogen free at the time of sampling 
while others were highly colonized. This illustrates the weakness of not only our 
challenge model, but also all current experimental models for these three pathogens. 
Our limited understanding of the extremely complex microbial ecology of the 
gastrointestinal environment makes model design crude at best and more often than not 
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flawed. Proper experimental models require an increased understanding of the host, the 
microbes, the relationship between intestinal microbes and the host, as well as factors 
that control microbial community dynamics within the gastrointestinal tract. Presently 
this area of research is in its’ infancy, however we are making steps towards a more 
complete holistic understanding of these complex relationships. 
In conclusion, although the approaches used in these studies may show promise for 
the reduction of pathogens in broiler chickens, a more thorough and comprehensive 
understanding of the factors that help or hinder their efficacy is required. For oral 
administration of antibodies to be effective, the identification of the most appropriate 
virulence factors that should be used to immunize hens is essential. In instances when 
targeting a bacterial pathogen which is not normally a pathogen in the broiler chicken, 
as was the case with S. enteritidis and C. jejuni, this approach may not be useful. With a 
chicken pathogen such as C. perfringens however, this approach might be useful, and 
our results suggest that identification and use of the correct target antigen is crucial. In 
this respect, the most appropriate direction for further research may be assessing the 
usefulness of raising HEA specific to the α-toxin. In addition, our results support the 
notion that diet may be our most effective way to manage the microbial ecology in the 
absence of medicated feed. At the very least, understanding the dietary factors which 
predispose birds to specific diseases such as necrotic enteritis will go a long way to 
fighting disease in an antibiotic-free agricultural sector. In the end it may be that, due to 
the biological nature of these approaches, they may never be as effective as antibiotics; 
however they will have to deliver consistent and reliable results if they are to receive 
widespread acceptance and use.
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9. APPENDICES 
9.1. Appendix A 
Supplemental images for Chapter 5. 
To evaluate HEA-mediated agglutination, 3.3 X 108 CFUs/mL C. perfringens were 
incubated with anti- C. perfringens and anti-CTX HEA at an endpoint tire of 1:72,000 
for 15 min at room temperature. The incubated solutions were placed on glass slides 
and agglutination visually evaluated under 400X magnification on a Axiostar plus Zeiss 
microscope (Carl Zeiss Vision GmbH, Germany) fitted with Axiocam MRc camera. 
The resulting images are shown in Figure A.1 
Figure A.2 is a photomicrograph showing typical lesions found in the cecal tonsil 
region of birds challenged with C. perfringens in Chapter 5. Images are of hemotoxylin- 
and eosin- stained, formalin-fixed tissue using a Axiostar plus Zeiss microscope (Carl 
Zeiss Vision GmbH, Germany) fitted with Axiocam MRc camera. 
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Figure A.1. Photograph taken under phase contrast (400X) showing the in vitro 
agglutination of C. perfringens by anti-Ctx HEA (A) compared to that of anti- C. 
perfringens HEA (B). The antibodies were diluted 1:72,000 and incubated in the 
presence of 8.50 log10 CFUs C. perfringens. 
 
 
 
 
 
 
A B
 169
 
Figure A.2. Micrograph of H&E stained cecal tonsil cross sections at 50X (A) and 
400X (B). Hemorrhagic lesions are evident by the infiltration of erythrocytes at the 
villus tips. 
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